Document:

Exhibit 10.6

 

Immunome, Inc.

2020
Equity Incentive Plan

 

Adopted
by the Board of Directors: September 18, 2020

Approved
by the Stockholders: September 22, 2020

 

    

     

    

 

Table
of Contents

 

Page

 

		1.	General.	1

 

		2.	Shares Subject to the Plan.	1

 

		3.	Eligibility and Limitations.	2

 

		4.	Options and Stock Appreciation Rights.	3

 

		5.	Awards Other Than Options and Stock Appreciation Rights.	6

 

		6.	Adjustments upon Changes in Common Stock; Other Corporate Events.	8

 

		7.	Administration.	10

 

		8.	Tax Withholding	12

 

		9.	Miscellaneous.	13

 

		10.	Covenants of the Company.	16

 

		11.	Additional Rules for Awards Subject to Section 409A.	16

 

		12.	Severability.	19

 

		13.	Termination of the Plan.	19

 

		14.	Definitions	20

 

    i

     

    

 

1.            General.

 

(a)            Successor
to and Continuation of Prior Plans. The Plan is the successor to and continuation of the Prior Plans. As of the Effective Date,
(i) no additional awards may be granted under the Prior Plans; (ii) the Prior Plans’ Available Reserve plus any
Returning Shares will become available for issuance pursuant to Awards granted under this Plan; and (iii) all outstanding
awards granted under the Prior Plans will remain subject to the terms of the applicable Prior Plan (except to the extent such outstanding
awards result in Returning Shares that become available for issuance pursuant to Awards granted under this Plan). All Awards granted
under this Plan will be subject to the terms of this Plan.

 

(b)            Plan
Purpose. The Company, by means of the Plan, seeks to secure and retain the services of Employees, Directors and Consultants,
to provide incentives for such persons to exert maximum efforts for the success of the Company and any Affiliate and to provide
a means by which such persons may be given an opportunity to benefit from increases in value of the Common Stock through the granting
of Awards.

 

(c)            Available
Awards. The Plan provides for the grant of the following Awards: (i) Incentive Stock Options; (ii) Nonstatutory Stock
Options; (iii) SARs; (iv) Restricted Stock Awards; (v) RSU Awards; (vi) Performance Awards; and (vii) Other
Awards.

 

(d)            Adoption
Date; Effective Date. The Plan will come into existence on the Adoption Date, but no Award may be granted prior to the Effective
Date.

 

2.            Shares
Subject to the Plan.

 

(a)            Share
Reserve. Subject to adjustment in accordance with Section 2(c) and any adjustments as necessary to implement any
Capitalization Adjustments, the aggregate number of shares of Common Stock that may be issued pursuant to Awards will not exceed
2,000,000 shares, which number is the sum of: (i) 1,701,723 new shares, plus (ii) the Prior Plans’ Available Reserve,
and plus (iii) the number of Returning Shares, if any, as such shares become available from time to time.

 

In addition, subject to any adjustments
as necessary to implement any Capitalization Adjustments, such aggregate number of shares of Common Stock will automatically increase
on January 1 of each calendar year for a period of ten years commencing on January 1, 2021 and ending on (and including)
January 1, 2030, in a number of shares of Common Stock equal to 4% of the total number of shares of Capital Stock outstanding
on December 31 of the preceding calendar year; provided, however that the Board may act prior to January 1 of a given
calendar year to provide that the increase for such year will be a lesser number of shares of Common Stock.

 

(b)            Aggregate
Incentive Stock Option Limit. Notwithstanding anything to the contrary in Section 2(a) and subject to any adjustments
as necessary to implement any Capitalization Adjustments, the aggregate maximum number of shares of Common Stock that may be issued
pursuant to the exercise of Incentive Stock Options is 10,000,000 shares.

 

(c)            Share
Reserve Operation.

 

(i)            Limit
Applies to Common Stock Issued Pursuant to Awards. For clarity, the Share Reserve is a limit on the number of shares of Common
Stock that may be issued pursuant to Awards and does not limit the granting of Awards, except that the Company will keep available
at all times the number of shares of Common Stock reasonably required to satisfy its obligations to issue shares pursuant to such
Awards. Shares may be issued in connection with a merger or acquisition as permitted by, as applicable, Nasdaq Listing Rule 5635(c),
NYSE Listed Company Manual Section 303A.08, NYSE American Company Guide Section 711 or other applicable rule, and such
issuance will not reduce the number of shares available for issuance under the Plan.

 

    1.

     

    

 

(ii)            Actions
that Do Not Constitute Issuance of Common Stock and Do Not Reduce Share Reserve. The following actions do not result in an
issuance of shares under the Plan and accordingly do not reduce the number of shares subject to the Share Reserve and available
for issuance under the Plan: (1) the expiration or termination of any portion of an Award without the shares covered by such
portion of the Award having been issued, (2) the settlement of any portion of an Award in cash (i.e., the Participant
receives cash rather than Common Stock), (3) the withholding of shares that would otherwise be issued by the Company to satisfy
the exercise, strike or purchase price of an Award; (4) the withholding of shares that would otherwise be issued by the Company
to satisfy a tax withholding obligation in connection with an Award.

 

(iii)            Reversion
of Previously Issued Shares of Common Stock to Share Reserve. The following shares of Common Stock previously issued pursuant
to an Award and accordingly initially deducted from the Share Reserve will be added back to the Share Reserve and again become
available for issuance under the Plan: (1) any shares that are forfeited back to or repurchased by the Company because of
a failure to meet a contingency or condition required for the vesting of such shares; (2) any shares that are reacquired by
the Company to satisfy the exercise, strike or purchase price of an Award; and (3) any shares that are reacquired by the Company
to satisfy a tax withholding obligation in connection with an Award.

 

3.            Eligibility
and Limitations.

 

(a)            Eligible
Award Recipients. Subject to the terms of the Plan, Employees, Directors and Consultants are eligible to receive Awards.

 

(b)            Specific
Award Limitations.

 

(i)            Limitations
on Incentive Stock Option Recipients. Incentive Stock Options may be granted only to Employees of the Company or a “parent
corporation” or “subsidiary corporation” thereof (as such terms are defined in Sections 424(e) and (f) of
the Code).

 

(ii)            Incentive
Stock Option $100,000 Limitation. To the extent that the aggregate Fair Market Value (determined at the time of grant) of Common
Stock with respect to which Incentive Stock Options are exercisable for the first time by any Optionholder during any calendar
year (under all plans of the Company and any Affiliates) exceeds $100,000 (or such other limit established in the Code) or otherwise
does not comply with the rules governing Incentive Stock Options, the Options or portions thereof that exceed such limit (according
to the order in which they were granted) or otherwise do not comply with such rules will be treated as Nonstatutory Stock
Options, notwithstanding any contrary provision of the applicable Option Agreement(s).

 

(iii)            Limitations
on Incentive Stock Options Granted to Ten Percent Stockholders. A Ten Percent Stockholder may not be granted an Incentive Stock
Option unless (i) the exercise price of such Option is at least 110% of the Fair Market Value on the date of grant of such
Option and (ii) the Option is not exercisable after the expiration of five years from the date of grant of such Option.

 

    2.

     

    

 

(iv)            Limitations
on Nonstatutory Stock Options and SARs. Nonstatutory Stock Options and SARs may not be granted to Employees, Directors and
Consultants who are providing Continuous Service only to any “parent” of the Company (as such term is defined in Rule 405)
unless the stock underlying such Awards is treated as “service recipient stock” under Section 409A because the
Awards are granted pursuant to a corporate transaction (such as a spin off transaction) or unless such Awards otherwise comply
with the distribution requirements of Section 409A.

 

(c)            Aggregate
Incentive Stock Option Limit. The aggregate maximum number of shares of Common Stock that may be issued pursuant to the exercise
of Incentive Stock Options is the number of shares specified in Section 2(b).

 

(d)            Non-Employee
Director Compensation Limit.  The aggregate value of all compensation granted or paid, as applicable, to any individual for
service as a Non-Employee Director with respect to any calendar year that follows the calendar year in which such individual is
first appointed or elected to the Board, including Awards granted and cash fees paid by the Company to such Non-Employee Director,
will not exceed $900,000 in total value, and with respect to the calendar year in which a Non-Employee Director is first appointed
or elected to the Board, will not exceed $$1,300,000 in total value, in each case calculating the value of any equity awards based
on the grant date fair value of such equity awards for financial reporting purposes.

 

4.            Options
and Stock Appreciation Rights.

 

Each Option and SAR
will have such terms and conditions as determined by the Board. Each Option will be designated in writing as an Incentive Stock
Option or Nonstatutory Stock Option at the time of grant; provided, however, that if an Option is not so designated, then
such Option will be a Nonstatutory Stock Option, and the shares purchased upon exercise of each type of Option will be separately
accounted for. Each SAR will be denominated in shares of Common Stock equivalents. The terms and conditions of separate Options
and SARs need not be identical; provided, however, that each Option Agreement and SAR Agreement will conform (through incorporation
of provisions hereof by reference in the Award Agreement or otherwise) to the substance of each of the following provisions:

 

(a)            Term.
Subject to Section 3(b) regarding Ten Percent Stockholders, no Option or SAR will be exercisable after the expiration
of ten years from the date of grant of such Award or such shorter period specified in the Award Agreement.

 

(b)            Exercise
or Strike Price. Subject to Section 3(b) regarding Ten Percent Stockholders, the exercise or strike price of each
Option or SAR will not be less than 100% of the Fair Market Value on the date of grant of such Award. Notwithstanding the foregoing,
an Option or SAR may be granted with an exercise or strike price lower than 100% of the Fair Market Value on the date of grant
of such Award if such Award is granted pursuant to an assumption of or substitution for another option or stock appreciation right
pursuant to a Corporate Transaction and in a manner consistent with the provisions of Sections 409A and, if applicable, 424(a) of
the Code.

 

(c)            Exercise
Procedure and Payment of Exercise Price for Options. In order to exercise an Option, the Participant must provide notice of
exercise to the Plan Administrator in accordance with the procedures specified in the Option Agreement or otherwise provided by
the Company. The Board has the authority to grant Options that do not permit all of the following methods of payment (or otherwise
restrict the ability to use certain methods) and to grant Options that require the consent of the Company to utilize a particular
method of payment. The exercise price of an Option may be paid, to the extent permitted by Applicable Law and as determined by
the Board, by one or more of the following methods of payment to the extent set forth in the Option Agreement:

 

    3.

     

    

 

(i)            by
cash or check, bank draft or money order payable to the Company;

 

(ii)           pursuant
to a “cashless exercise” program developed under Regulation T as promulgated by the Federal Reserve Board that, prior
to the issuance of the Common Stock subject to the Option, results in either the receipt of cash (or check) by the Company or the
receipt of irrevocable instructions to pay the exercise price to the Company from the sales proceeds;

 

(iii)         by
delivery to the Company (either by actual delivery or attestation) of shares of Common Stock that are already owned by the Participant
free and clear of any liens, claims, encumbrances or security interests, with a Fair Market Value on the date of exercise that
does not exceed the exercise price, provided that (1) at the time of exercise the Common Stock is publicly traded, (2) any
remaining balance of the exercise price not satisfied by such delivery is paid by the Participant in cash or other permitted form
of payment, (3) such delivery would not violate any Applicable Law or agreement restricting the redemption of the Common Stock,
(4) any certificated shares are endorsed or accompanied by an executed assignment separate from certificate, and (5) such
shares have been held by the Participant for any minimum period necessary to avoid adverse accounting treatment as a result of
such delivery;

 

(iv)           if
the Option is a Nonstatutory Stock Option, by a “net exercise” arrangement pursuant to which the Company will reduce
the number of shares of Common Stock issuable upon exercise by the largest whole number of shares with a Fair Market Value on the
date of exercise that does not exceed the exercise price, provided that (1) such shares used to pay the exercise price will
not be exercisable thereafter and (2) any remaining balance of the exercise price not satisfied by such net exercise is paid
by the Participant in cash or other permitted form of payment; or

 

(v)            in
any other form of consideration that may be acceptable to the Board and permissible under Applicable Law.

 

(d)            Exercise
Procedure and Payment of Appreciation Distribution for SARs. In order to exercise any SAR, the Participant must provide notice
of exercise to the Plan Administrator in accordance with the SAR Agreement. The appreciation distribution payable to a Participant
upon the exercise of a SAR will not be greater than an amount equal to the excess of (i) the aggregate Fair Market Value on
the date of exercise of a number of shares of Common Stock equal to the number of Common Stock equivalents that are vested and
being exercised under such SAR, over (ii) the strike price of such SAR. Such appreciation distribution may be paid to the
Participant in the form of Common Stock or cash (or any combination of Common Stock and cash) or in any other form of payment,
as determined by the Board and specified in the SAR Agreement.

 

(e)            Transferability.
Options and SARs may not be transferred to third party financial institutions for value. The Board may impose such additional limitations
on the transferability of an Option or SAR as it determines. In the absence of any such determination by the Board, the following
restrictions on the transferability of Options and SARs will apply, provided that except as explicitly provided herein, neither
an Option nor a SAR may be transferred for consideration and provided, further, that if an Option is an Incentive Stock
Option, such Option may be deemed to be a Nonstatutory Stock Option as a result of such transfer:

 

(i)            Restrictions
on Transfer. An Option or SAR will not be transferable, except by will or by the laws of descent and distribution, and will
be exercisable during the lifetime of the Participant only by the Participant; provided, however, that the Board may permit
transfer of an Option or SAR in a manner that is not prohibited by applicable tax and securities laws upon the Participant’s
request, including to a trust if the Participant is considered to be the sole beneficial owner of such trust (as determined under
Section 671 of the Code and applicable state law) while such Option or SAR is held in such trust, provided that the Participant
and the trustee enter into a transfer and other agreements required by the Company.

 

    4.

     

    

 

(ii)            Domestic
Relations Orders. Notwithstanding the foregoing, subject to the execution of transfer documentation in a format acceptable
to the Company and subject to the approval of the Board or a duly authorized Officer, an Option or SAR may be transferred pursuant
to a domestic relations order.

 

(f)            Vesting.
The Board may impose such restrictions on or conditions to the vesting and/or exercisability of an Option or SAR as determined
by the Board. Except as otherwise provided in the Award Agreement or other written agreement between a Participant and the Company
or an Affiliate, vesting of Options and SARs will cease upon termination of the Participant’s Continuous Service.

 

(g)            Termination
of Continuous Service for Cause. Except as explicitly otherwise provided in the Award Agreement or other written agreement
between a Participant and the Company or an Affiliate, if a Participant’s Continuous Service is terminated for Cause, the
Participant’s Options and SARs will terminate and be forfeited immediately upon such termination of Continuous Service, and
the Participant will be prohibited from exercising any portion (including any vested portion) of such Awards on and after the date
of such termination of Continuous Service and the Participant will have no further right, title or interest in such forfeited Award,
the shares of Common Stock subject to the forfeited Award, or any consideration in respect of the forfeited Award.

 

(h)            Post-Termination
Exercise Period Following Termination of Continuous Service for Reasons Other than Cause. Subject to Section 4(i), if
a Participant’s Continuous Service terminates for any reason other than for Cause, the Participant may exercise his or her
Option or SAR to the extent vested, but only within the following period of time or, if applicable, such other period of time provided
in the Award Agreement or other written agreement between a Participant and the Company or an Affiliate; provided, however,
that in no event may such Award be exercised after the expiration of its maximum term (as set forth in Section 4(a)):

 

(i)            three
months following the date of such termination if such termination is a termination without Cause (other than any termination due
to the Participant’s Disability or death);

 

(ii)          12
months following the date of such termination if such termination is due to the Participant’s Disability;

 

(iii)         18
months following the date of such termination if such termination is due to the Participant’s death; or

 

(iv)          18
months following the date of the Participant’s death if such death occurs following the date of such termination but during
the period such Award is otherwise exercisable (as provided in (i) or (ii) above).

 

Following the date of such termination,
to the extent the Participant does not exercise such Award within the applicable Post-Termination Exercise Period (or, if earlier,
prior to the expiration of the maximum term of such Award), such unexercised portion of the Award will terminate, and the Participant
will have no further right, title or interest in terminated Award, the shares of Common Stock subject to the terminated Award,
or any consideration in respect of the terminated Award.

 

    5.

     

    

 

(i)            Restrictions
on Exercise; Extension of Exercisability. A Participant may not exercise an Option or SAR at any time that the issuance of
shares of Common Stock upon such exercise would violate Applicable Law. Except as otherwise provided in the Award Agreement or
other written agreement between a Participant and the Company or an Affiliate, if a Participant’s Continuous Service terminates
for any reason other than for Cause and, at any time during the last thirty days of the applicable Post-Termination Exercise Period:
(i) the exercise of the Participant’s Option or SAR would be prohibited solely because the issuance of shares of Common
Stock upon such exercise would violate Applicable Law, or (ii) the immediate sale of any shares of Common Stock issued upon
such exercise would violate the Company’s Trading Policy, then the applicable Post-Termination Exercise Period will be extended
to the last day of the calendar month that commences following the date the Award would otherwise expire, with an additional extension
of the exercise period to the last day of the next calendar month to apply if any of the foregoing restrictions apply at any time
during such extended exercise period, generally without limitation as to the maximum permitted number of extensions; provided,
however, that in no event may such Award be exercised after the expiration of its maximum term (as set forth in Section 4(a)).

 

(j)            Non-Exempt
Employees. No Option or SAR, whether or not vested, granted to an Employee who is a non-exempt employee for purposes of the
Fair Labor Standards Act of 1938, as amended, will be first exercisable for any shares of Common Stock until at least six months
following the date of grant of such Award. Notwithstanding the foregoing, in accordance with the provisions of the Worker Economic
Opportunity Act, any vested portion of such Award may be exercised earlier than six months following the date of grant of such
Award in the event of (i) such Participant’s death or Disability, (ii) a Corporate Transaction in which such Award
is not assumed, continued or substituted, (iii) a Change in Control, or (iv) such Participant’s retirement (as
such term may be defined in the Award Agreement or another applicable agreement or, in the absence of any such definition, in accordance
with the Company’s then current employment policies and guidelines). This Section 4(j) is intended to operate so
that any income derived by a non-exempt employee in connection with the exercise or vesting of an Option or SAR will be exempt
from his or her regular rate of pay.

 

(k)            Whole
Shares. Options and SARs may be exercised only with respect to whole shares of Common Stock or their equivalents.

 

5.            Awards
Other Than Options and Stock Appreciation Rights.

 

(a)            Restricted
Stock Awards and RSU Awards. Each Restricted Stock Award and RSU Award will have such terms and conditions as determined by
the Board; provided, however, that each Restricted Stock Award Agreement and RSU Award Agreement will conform (through incorporation
of the provisions hereof by reference in the Award Agreement or otherwise) to the substance of each of the following provisions:

 

(i)            Form of
Award.

 

(1)            RSAs:
To the extent consistent with the Company’s Bylaws, at the Board’s election, shares of Common Stock subject to a Restricted
Stock Award may be (i) held in book entry form subject to the Company’s instructions until such shares become vested
or any other restrictions lapse, or (ii) evidenced by a certificate, which certificate will be held in such form and manner
as determined by the Board. Unless otherwise determined by the Board, a Participant will have voting and other rights as a stockholder
of the Company with respect to any shares subject to a Restricted Stock Award.

 

    6.

     

    

 

(2)            RSUs:
A RSU Award represents a Participant’s right to be issued on a future date the number of shares of Common Stock that is equal
to the number of restricted stock units subject to the RSU Award. As a holder of a RSU Award, a Participant is an unsecured creditor
of the Company with respect to the Company's unfunded obligation, if any, to issue shares of Common Stock in settlement of such
Award and nothing contained in the Plan or any RSU Agreement, and no action taken pursuant to its provisions, will create or be
construed to create a trust of any kind or a fiduciary relationship between a Participant and the Company or an Affiliate or any
other person. A Participant will not have voting or any other rights as a stockholder of the Company with respect to any RSU Award
(unless and until shares are actually issued in settlement of a vested RSU Award).

 

(ii)            Consideration.

 

(1)            RSA:
A Restricted Stock Award may be granted in consideration for (A) cash or check, bank draft or money order payable to the Company,
(B) past services to the Company or an Affiliate, or (C) any other form of consideration (including future services)
as the Board may determine and permissible under Applicable Law.

 

(2)            RSU:
Unless otherwise determined by the Board at the time of grant, a RSU Award will be granted in consideration for the Participant’s
services to the Company or an Affiliate, such that the Participant will not be required to make any payment to the Company (other
than such services) with respect to the grant or vesting of the RSU Award, or the issuance of any shares of Common Stock pursuant
to the RSU Award. If, at the time of grant, the Board determines that any consideration must be paid by the Participant (in a form
other than the Participant’s services to the Company or an Affiliate) upon the issuance of any shares of Common Stock in
settlement of the RSU Award, such consideration may be paid in any form of consideration as the Board may determine and permissible
under Applicable Law.

 

(iii)            Vesting.
The Board may impose such restrictions on or conditions to the vesting of a Restricted Stock Award or RSU Award as determined
by the Board and which may vary. Except as otherwise provided in the Award Agreement or other written agreement between a Participant
and the Company or an Affiliate, vesting of Restricted Stock Awards and RSU Awards will cease upon termination of the Participant’s
Continuous Service.

 

(iv)            Termination
of Continuous Service. Except as otherwise provided in the Award Agreement or other written agreement between a Participant
and the Company or an Affiliate, if a Participant’s Continuous Service terminates for any reason, (i) the Company may
receive through a forfeiture condition or a repurchase right any or all of the shares of Common Stock held by the Participant under
his or her Restricted Stock Award that have not vested as of the date of such termination as set forth in the Restricted Stock
Award Agreement and (ii) any portion of his or her RSU Award that has not vested will be forfeited upon such termination and
the Participant will have no further right, title or interest in the RSU Award, the shares of Common Stock issuable pursuant to
the RSU Award, or any consideration in respect of the RSU Award.

 

(v)            Dividends
and Dividend Equivalents. Dividends or dividend equivalents may be paid or credited, as applicable, with respect to any shares
of Common Stock subject to a Restricted Stock Award or RSU Award, as determined by the Board and specified in the Award Agreement).

 

(vi)            Settlement
of RSU Awards. A RSU Award may be settled by the issuance of shares of Common Stock or cash (or any combination thereof) or
in any other form of payment, as determined by the Board and specified in the RSU Award Agreement. At the time of grant, the Board
may determine to impose such restrictions or conditions that delay such delivery to a date following the vesting of the RSU Award.

 

    7.

     

    

 

(b)            Performance
Awards. With respect to any Performance Award, the length of any Performance Period, the Performance Goals to be achieved during
the Performance Period, the other terms and conditions of such Award, and the measure of whether and to what degree such Performance
Goals have been attained will be determined by the Board.

 

(c)            Other
Awards. Other forms of Awards valued in whole or in part by reference to, or otherwise based on, Common Stock, including the
appreciation in value thereof (e.g., options or stock rights with an exercise price or strike price less than 100% of the Fair
Market Value at the time of grant) may be granted either alone or in addition to Awards provided for under Section 4 and the
preceding provisions of this Section 5. Subject to the provisions of the Plan, the Board will have sole and complete discretion
to determine the persons to whom and the time or times at which such Other Awards will be granted, the number of shares of Common
Stock (or the cash equivalent thereof) to be granted pursuant to such Other Awards and all other terms and conditions of such Other
Awards.

 

6.            Adjustments
upon Changes in Common Stock; Other Corporate Events.

 

(a)            Capitalization
Adjustments. In the event of a Capitalization Adjustment, the Board shall appropriately and proportionately adjust: (i) the
class(es) and maximum number of shares of Common Stock subject to the Plan and the maximum number of shares by which the Share
Reserve may annually increase pursuant to Section 2(a), (ii) the class(es) and maximum number of shares that may be issued
pursuant to the exercise of Incentive Stock Options pursuant to Section 2(a), and (iii) the class(es) and number of securities
and exercise price, strike price or purchase price of Common Stock subject to outstanding Awards. The Board shall make such adjustments,
and its determination shall be final, binding and conclusive. Notwithstanding the foregoing, no fractional shares or rights for
fractional shares of Common Stock shall be created in order to implement any Capitalization Adjustment. The Board shall determine
an equivalent benefit for any fractional shares or fractional shares that might be created by the adjustments referred to in the
preceding provisions of this Section.

 

(b)            Dissolution
or Liquidation. Except as otherwise provided in the Award Agreement, in the event of a dissolution or liquidation of the Company,
all outstanding Awards (other than Awards consisting of vested and outstanding shares of Common Stock not subject to a forfeiture
condition or the Company’s right of repurchase) will terminate immediately prior to the completion of such dissolution or
liquidation, and the shares of Common Stock subject to the Company’s repurchase rights or subject to a forfeiture condition
may be repurchased or reacquired by the Company notwithstanding the fact that the holder of such Award is providing Continuous
Service, provided, however, that the Board may determine to cause some or all Awards to become fully vested, exercisable
and/or no longer subject to repurchase or forfeiture (to the extent such Awards have not previously expired or terminated) before
the dissolution or liquidation is completed but contingent on its completion.

 

(c)            Corporate
Transaction. The following provisions will apply to Awards in the event of a Corporate Transaction unless otherwise provided
in the instrument evidencing the Award or any other written agreement between the Company or any Affiliate and the Participant
or unless otherwise expressly provided by the Board. The Board has sole and complete discretion to determine to accelerate the
vesting and exercisability of all or any Awards in the event of a Corporate Transaction.

 

(i)            Awards
May Be Assumed. In the event of a Corporate Transaction, any surviving corporation or acquiring corporation (or the surviving
or acquiring corporation’s parent company) may assume or continue any or all Awards outstanding under the Plan or may substitute
similar awards for Awards outstanding under the Plan (including but not limited to, awards to acquire the same consideration paid
to the stockholders of the Company pursuant to the Corporate Transaction), and any reacquisition or repurchase rights held by the
Company in respect of Common Stock issued pursuant to Awards may be assigned by the Company to the successor of the Company (or
the successor’s parent company, if any), in connection with such Corporate Transaction. A surviving corporation or acquiring
corporation (or its parent) may choose to assume or continue only a portion of an Award or substitute a similar award for only
a portion of an Award, or may choose to assume or continue the Awards held by some, but not all Participants. The terms of any
assumption, continuation or substitution will be set by the Board.

 

    8.

     

    

 

(ii)            Awards
Held by Current Participants. In the event of a Corporate Transaction in which the surviving corporation or acquiring corporation
(or its parent company) does not assume or continue such outstanding Awards or substitute similar awards for such outstanding Awards,
then with respect to Awards that have not been assumed, continued or substituted and that are held by Participants whose Continuous
Service has not terminated prior to the effective time of the Corporate Transaction (referred to as the “Current Participants”),
the vesting of such Awards (and, with respect to Options and Stock Appreciation Rights, the time when such Awards may be exercised)
will be accelerated in full to a date prior to the effective time of such Corporate Transaction (contingent upon the effectiveness
of the Corporate Transaction) as the Board determines (or, if the Board does not determine such a date, to the date that is five
(5) days prior to the effective time of the Corporate Transaction), and such Awards will terminate if not exercised (if applicable)
at or prior to the effective time of the Corporate Transaction, and any reacquisition or repurchase rights held by the Company
with respect to such Awards will lapse (contingent upon the effectiveness of the Corporate Transaction). With respect to the vesting
of Performance Awards that will accelerate upon the occurrence of a Corporate Transaction pursuant to this subsection (ii) and
that have multiple vesting levels depending on the level of performance, unless otherwise provided in the Award Agreement, the
vesting of such Performance Awards will accelerate at 100% of the target level upon the occurrence of the Corporate Transaction.
With respect to the vesting of Awards that will accelerate upon the occurrence of a Corporate Transaction pursuant to this subsection
(ii) and are settled in the form of a cash payment, such cash payment will be made no later than 30 days following the occurrence
of the Corporate Transaction..

 

(iii)            Awards
Held by Persons other than Current Participants. In the event of a Corporate Transaction in which the surviving corporation
or acquiring corporation (or its parent company) does not assume or continue such outstanding Awards or substitute similar awards
for such outstanding Awards, then with respect to Awards that have not been assumed, continued or substituted and that are held
by persons other than Current Participants, such Awards will terminate if not exercised (if applicable) prior to the occurence
of the Corporate Transaction; provided, however, that any reacquisition or repurchase rights held by the Company with respect
to such Awards will not terminate and may continue to be exercised notwithstanding the Corporate Transaction.

 

(iv)            Payment
for Awards in Lieu of Exercise. Notwithstanding the foregoing, in the event an Award will terminate if not exercised prior
to the effective time of a Corporate Transaction, the Board may provide, in its sole discretion, that the holder of such Award
may not exercise such Award but will receive a payment, in such form as may be determined by the Board, equal in value, at the
effective time, to the excess, if any, of (1) the value of the property the Participant would have received upon the exercise
of the Award (including, at the discretion of the Board, any unvested portion of such Award), over (2) any exercise price
payable by such holder in connection with such exercise.

 

(d)            Appointment
of Stockholder Representative. As a condition to the receipt of an Award under this Plan, a Participant will be deemed to have
agreed that the Award will be subject to the terms of any agreement governing a Corporate Transaction involving the Company, including,
without limitation, a provision for the appointment of a stockholder representative that is authorized to act on the Participant’s
behalf with respect to any escrow, indemnities and any contingent consideration.

 

    9.

     

    

 

(e)            No
Restriction on Right to Undertake Transactions. The grant of any Award under the Plan and the issuance of shares pursuant to
any Award does not affect or restrict in any way the right or power of the Company or the stockholders of the Company to make or
authorize any adjustment, recapitalization, reorganization or other change in the Company’s capital structure or its business,
any merger or consolidation of the Company, any issue of stock or of options, rights or options to purchase stock or of bonds,
debentures, preferred or prior preference stocks whose rights are superior to or affect the Common Stock or the rights thereof
or which are convertible into or exchangeable for Common Stock, or the dissolution or liquidation of the Company, or any sale or
transfer of all or any part of its assets or business, or any other corporate act or proceeding, whether of a similar character
or otherwise.

 

7.            Administration.

 

(a)            Administration
by Board. The Board will administer the Plan unless and until the Board delegates administration of the Plan to a Committee
or Committees, as provided in subsection (c) below.

 

(b)            Powers
of Board. The Board will have the power, subject to, and within the limitations of, the express provisions of the Plan:

 

(i)            To
determine from time to time (1) which of the persons eligible under the Plan will be granted Awards; (2) when and how
each Award will be granted; (3) what type or combination of types of Award will be granted; (4) the provisions of each
Award granted (which need not be identical), including the time or times when a person will be permitted to receive an issuance
of Common Stock or other payment pursuant to an Award; (5) the number of shares of Common Stock or cash equivalent with respect
to which an Award will be granted to each such person; (6) the Fair Market Value applicable to an Award; and (7) the
terms of any Performance Award that is not valued in whole or in part by reference to, or otherwise based on, the Class A
Common Stock, including the amount of cash payment or other property that may be earned and the timing of payment.

 

(ii)            To
construe and interpret the Plan and Awards granted under it, and to establish, amend and revoke rules and regulations for
its administration. The Board, in the exercise of this power, may correct any defect, omission or inconsistency in the Plan or
in any Award Agreement, in a manner and to the extent it deems necessary or expedient to make the Plan or Award fully effective.

 

(iii)            To
settle all controversies regarding the Plan and Awards granted under it.

 

(iv)            To
accelerate the time at which an Award may first be exercised or the time during which an Award or any part thereof will vest, notwithstanding
the provisions in the Award Agreement stating the time at which it may first be exercised or the time during which it will vest.

 

(v)            To
prohibit the exercise of any Option, SAR or other exercisable Award during a period of up to 30 days prior to the consummation
of any pending stock dividend, stock split, combination or exchange of shares, merger, consolidation or other distribution (other
than normal cash dividends) of Company assets to stockholders, or any other change affecting the shares of Common Stock or the
share price of the Common Stock including any Corporate Transaction, for reasons of administrative convenience.

 

(vi)            To
suspend or terminate the Plan at any time. Suspension or termination of the Plan will not Materially Impair rights and obligations
under any Award granted while the Plan is in effect except with the written consent of the affected Participant.

 

    10.

     

    

 

(vii)           To
amend the Plan in any respect the Board deems necessary or advisable; provided, however, that stockholder approval will
be required for any amendment to the extent required by Applicable Law. Except as provided above, rights under any Award granted
before amendment of the Plan will not be Materially Impaired by any amendment of the Plan unless (1) the Company requests
the consent of the affected Participant, and (2) such Participant consents in writing.

 

(viii)          To
submit any amendment to the Plan for stockholder approval.

 

(ix)            To
approve forms of Award Agreements for use under the Plan and to amend the terms of any one or more Awards, including, but not limited
to, amendments to provide terms more favorable to the Participant than previously provided in the Award Agreement, subject to any
specified limits in the Plan that are not subject to Board discretion; provided however, that, a Participant’s rights
under any Award will not be Materially Impaired by any such amendment unless (1) the Company requests the consent of the affected
Participant, and (2) such Participant consents in writing.

 

(x)             Generally,
to exercise such powers and to perform such acts as the Board deems necessary or expedient to promote the best interests of the
Company and that are not in conflict with the provisions of the Plan or Awards.

 

(xi)            To
adopt such procedures and sub-plans as are necessary or appropriate to permit and facilitate participation in the Plan by, or take
advantage of specific tax treatment for Awards granted to, Employees, Directors or Consultants who are foreign nationals or employed
outside the United States (provided that Board approval will not be necessary for immaterial modifications to the Plan or any Award
Agreement to ensure or facilitate compliance with the laws of the relevant foreign jurisdiction).

 

(xii)           To
effect, at any time and from time to time, subject to the consent of any Participant whose Award is Materially Impaired by such
action, (1) the reduction of the exercise price (or strike price) of any outstanding Option or SAR; (2) the cancellation
of any outstanding Option or SAR and the grant in substitution therefor of (A) a new Option, SAR, Restricted Stock Award,
RSU Award or Other Award, under the Plan or another equity plan of the Company, covering the same or a different number of shares
of Common Stock, (B) cash and/or (C) other valuable consideration (as determined by the Board); or (3) any other
action that is treated as a repricing under generally accepted accounting principles.

 

(c)            Delegation
to Committee.

 

(i)              General. The Board may delegate some or all of the administration of the Plan to a Committee or
Committees. If administration of the Plan is delegated to a Committee, the Committee will have, in connection with the
administration of the Plan, the powers theretofore possessed by the Board that have been delegated to the Committee,
including the power to delegate to another Committee or a subcommittee of the Committee any of the administrative powers the
Committee is authorized to exercise (and references in this Plan to the Board will thereafter be to the Committee or
subcommittee), subject, however, to such resolutions, not inconsistent with the provisions of the Plan, as may be adopted
from time to time by the Board. Each Committee may retain the authority to concurrently administer the Plan with Committee or
subcommittee to which it has delegated its authority hereunder and may, at any time, revest in such Committee some or all of
the powers previously delegated. The Board may retain the authority to concurrently administer the Plan with any Committee
and may, at any time, revest in the Board some or all of the powers previously delegated.

 

    11.

     

    

 

(ii)            Rule 16b-3
Compliance. To the extent an Award is intended to qualify for the exemption from Section 16(b) of the Exchange Act
that is available under Rule 16b-3 of the Exchange Act, the Award will be granted by the Board or a Committee that consists
solely of two or more Non-Employee Directors, as determined under Rule 16b-3(b)(3) of the Exchange Act and thereafter
any action establishing or modifying the terms of the Award will be approved by the Board or a Committee meeting such requirements
to the extent necessary for such exemption to remain available.

 

(d)            Effect
of Board’s Decision. All determinations, interpretations and constructions made by the Board or any Committee in good
faith will not be subject to review by any person and will be final, binding and conclusive on all persons.

 

(e)            Delegation
to an Officer. The Board or any Committee may delegate to one or more Officers the authority to do one or both of the following
(i) designate Employees who are not Officers to be recipients of Options and SARs (and, to the extent permitted by Applicable
Law, other types of Awards) and, to the extent permitted by Applicable Law, the terms thereof, and (ii) determine the number
of shares of Common Stock to be subject to such Awards granted to such Employees; provided, however, that the resolutions or charter
adopted by the Board or any Committee evidencing such delegation will specify the total number of shares of Common Stock that may
be subject to the Awards granted by such Officer and that such Officer may not grant an Award to himself or herself. Any such Awards
will be granted on the applicable form of Award Agreement most recently approved for use by the Board or the Committee, unless
otherwise provided in the resolutions approving the delegation authority. Notwithstanding anything to the contrary herein, neither
the Board nor any Committee may delegate to an Officer who is acting solely in the capacity of an Officer (and not also as a Director)
the authority to determine the Fair Market Value.

 

8.            Tax
Withholding

 

(a)            Withholding
Authorization. As a condition to acceptance of any Award under the Plan, a Participant authorizes withholding from payroll
and any other amounts payable to such Participant, and otherwise agree to make adequate provision for (including), any sums required
to satisfy any U.S. federal, state, local and/or foreign tax or social insurance contribution withholding obligations of the Company
or an Affiliate, if any, which arise in connection with the exercise, vesting or settlement of such Award, as applicable. Accordingly,
a Participant may not be able to exercise an Award even though the Award is vested, and the Company shall have no obligation to
issue shares of Common Stock subject to an Award, unless and until such obligations are satisfied.

 

(b)            Satisfaction
of Withholding Obligation. To the extent permitted by the terms of an Award Agreement, the Company may, in its sole discretion,
satisfy any U.S. federal, state, local and/or foreign tax or social insurance withholding obligation relating to an Award by any
of the following means or by a combination of such means: (i) causing the Participant to tender a cash payment; (ii) withholding
shares of Common Stock from the shares of Common Stock issued or otherwise issuable to the Participant in connection with the Award;
(iii) withholding cash from an Award settled in cash; (iv) withholding payment from any amounts otherwise payable to
the Participant; (v) by allowing a Participant to effectuate a “cashless exercise” pursuant to a program developed
under Regulation T as promulgated by the Federal Reserve Board, or (vi) by such other method as may be set forth in the Award
Agreement.

 

    12.

     

    

 

(c)            No
Obligation to Notify or Minimize Taxes; No Liability to Claims. Except as required by Applicable Law the Company has no duty
or obligation to any Participant to advise such holder as to the time or manner of exercising such Award. Furthermore, the Company
has no duty or obligation to warn or otherwise advise such holder of a pending termination or expiration of an Award or a possible
period in which the Award may not be exercised. The Company has no duty or obligation to minimize the tax consequences of an Award
to the holder of such Award and will not be liable to any holder of an Award for any adverse tax consequences to such holder in
connection with an Award. As a condition to accepting an Award under the Plan, each Participant (i) agrees to not make any
claim against the Company, or any of its Officers, Directors, Employees or Affiliates related to tax liabilities arising from such
Award or other Company compensation and (ii) acknowledges that such Participant was advised to consult with his or her own
personal tax, financial and other legal advisors regarding the tax consequences of the Award and has either done so or knowingly
and voluntarily declined to do so. Additionally, each Participant acknowledges any Option or SAR granted under the Plan is exempt
from Section 409A only if the exercise or strike price is at least equal to the “fair market value” of the Common
Stock on the date of grant as determined by the Internal Revenue Service and there is no other impermissible deferral of compensation
associated with the Award. Additionally, as a condition to accepting an Option or SAR granted under the Plan, each Participant
agrees not make any claim against the Company, or any of its Officers, Directors, Employees or Affiliates in the event that the
Internal Revenue Service asserts that such exercise price or strike price is less than the “fair market value” of the
Common Stock on the date of grant as subsequently determined by the Internal Revenue Service.

 

(d)            Withholding
Indemnification.  As a condition to accepting an Award under the Plan, in the event that the amount of the Company’s
and/or its Affiliate’s withholding obligation in connection with such Award was greater than the amount actually withheld
by the Company and/or its Affiliates, each Participant agrees to indemnify and hold the Company and/or its Affiliates harmless
from any failure by the Company and/or its Affiliates to withhold the proper amount.

 

9.            Miscellaneous.

 

(a)            Source
of Shares. The stock issuable under the Plan will be shares of authorized but unissued or reacquired Common Stock, including
shares repurchased by the Company on the open market or otherwise.

 

(b)            Use
of Proceeds from Sales of Common Stock. Proceeds from the sale of shares of Common Stock pursuant to Awards will constitute
general funds of the Company.

 

(c)            Corporate
Action Constituting Grant of Awards. Corporate action constituting a grant by the Company of an Award to any Participant will
be deemed completed as of the date of such corporate action, unless otherwise determined by the Board, regardless of when the instrument,
certificate, or letter evidencing the Award is communicated to, or actually received or accepted by, the Participant. In the event
that the corporate records (e.g., Board consents, resolutions or minutes) documenting the corporate action approving the grant
contain terms (e.g., exercise price, vesting schedule or number of shares) that are inconsistent with those in the Award Agreement
or related grant documents as a result of a clerical error in the Award Agreement or related grant documents, the corporate records
will control and the Participant will have no legally binding right to the incorrect term in the Award Agreement or related grant
documents.

 

(d)            Stockholder
Rights. No Participant will be deemed to be the holder of, or to have any of the rights of a holder with respect to, any shares
of Common Stock subject to such Award unless and until (i) such Participant has satisfied all requirements for exercise of
the Award pursuant to its terms, if applicable, and (ii) the issuance of the Common Stock subject to such Award is reflected
in the records of the Company.

 

    13.

     

    

 

(e)            No
Employment or Other Service Rights. Nothing in the Plan, any Award Agreement or any other instrument executed thereunder or
in connection with any Award granted pursuant thereto will confer upon any Participant any right to continue to serve the Company
or an Affiliate in the capacity in effect at the time the Award was granted or affect the right of the Company or an Affiliate
to terminate at will and without regard to any future vesting opportunity that a Participant may have with respect to any Award
(i) the employment of an Employee with or without notice and with or without cause, (ii) the service of a Consultant
pursuant to the terms of such Consultant’s agreement with the Company or an Affiliate, or (iii) the service of a Director
pursuant to the Bylaws of the Company or an Affiliate, and any applicable provisions of the corporate law of the state or foreign
jurisdiction in which the Company or the Affiliate is incorporated, as the case may be. Further, nothing in the Plan, any Award
Agreement or any other instrument executed thereunder or in connection with any Award will constitute any promise or commitment
by the Company or an Affiliate regarding the fact or nature of future positions, future work assignments, future compensation or
any other term or condition of employment or service or confer any right or benefit under the Award or the Plan unless such right
or benefit has specifically accrued under the terms of the Award Agreement and/or Plan.

 

(f)            Change
in Time Commitment. In the event a Participant’s regular level of time commitment in the performance of his or her services
for the Company and any Affiliates is reduced (for example, and without limitation, if the Participant is an Employee of the Company
and the Employee has a change in status from a full-time Employee to a part-time Employee or takes an extended leave of absence)
after the date of grant of any Award to the Participant, the Board may determine, to the extent permitted by Applicable Law, to
(i) make a corresponding reduction in the number of shares or cash amount subject to any portion of such Award that is scheduled
to vest or become payable after the date of such change in time commitment, and (ii) in lieu of or in combination with such
a reduction, extend the vesting or payment schedule applicable to such Award. In the event of any such reduction, the Participant
will have no right with respect to any portion of the Award that is so reduced or extended.

 

(g)            Execution
of Additional Documents. As a condition to accepting an Award under the Plan, the Participant agrees to execute any additional
documents or instruments necessary or desirable, as determined in the Plan Administrator’s sole discretion, to carry out
the purposes or intent of the Award, or facilitate compliance with securities and/or other regulatory requirements, in each case
at the Plan Administrator’s request.

 

(h)            Electronic
Delivery and Participation. Any reference herein or in an Award Agreement to a “written” agreement or document
will include any agreement or document delivered electronically, filed publicly at www.sec.gov (or any successor website thereto)
or posted on the Company’s intranet (or other shared electronic medium controlled by the Company to which the Participant
has access). By accepting any Award the Participant consents to receive documents by electronic delivery and to participate in
the Plan through any on-line electronic system established and maintained by the Plan Administrator or another third party selected
by the Plan Administrator. The form of delivery of any Common Stock (e.g., a stock certificate or electronic entry evidencing
such shares) shall be determined by the Company.

 

(i)            Clawback/Recovery.
All Awards granted under the Plan will be subject to recoupment in accordance with any clawback policy that the Company is required
to adopt pursuant to the listing standards of any national securities exchange or association on which the Company’s securities
are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other Applicable Law
and any clawback policy that the Company otherwise adopts, to the extent applicable and permissible under Applicable Law. In addition,
the Board may impose such other clawback, recovery or recoupment provisions in an Award Agreement as the Board determines necessary
or appropriate, including but not limited to a reacquisition right in respect of previously acquired shares of Common Stock or
other cash or property upon the occurrence of Cause. No recovery of compensation under such a clawback policy will be an event
giving rise to a Participant’s right to voluntary terminate employment upon a “resignation for good reason,”
or for a “constructive termination” or any similar term under any plan of or agreement with the Company.

 

    14.

     

    

 

(j)            Securities
Law Compliance. A Participant will not be issued any shares in respect of an Award unless either (i) the shares are registered
under the Securities Act; or (ii) the Company has determined that such issuance would be exempt from the registration requirements
of the Securities Act. Each Award also must comply with other Applicable Law governing the Award, and a Participant will not receive
such shares if the Company determines that such receipt would not be in material compliance with Applicable Law.

 

(k)           Transfer
or Assignment of Awards; Issued Shares. Except as expressly provided in the Plan or the form of Award Agreement, Awards granted
under the Plan may not be transferred or assigned by the Participant. After the vested shares subject to an Award have been issued,
or in the case of Restricted Stock and similar awards, after the issued shares have vested, the holder of such shares is free to
assign, hypothecate, donate, encumber or otherwise dispose of any interest in such shares provided that any such actions are in
compliance with the provisions herein, the terms of the Trading Policy and Applicable Law.

 

(l)             Effect
on Other Employee Benefit Plans.  The value of any Award granted under the Plan, as determined upon grant, vesting or settlement,
shall not be included as compensation, earnings, salaries, or other similar terms used when calculating any Participant’s
benefits under any employee benefit plan sponsored by the Company or any Affiliate, except as such plan otherwise expressly provides.
The Company expressly reserves its rights to amend, modify, or terminate any of the Company's or any Affiliate's employee benefit
plans.

 

(m)           Deferrals.
To the extent permitted by Applicable Law, the Board, in its sole discretion, may determine that the delivery of Common Stock or
the payment of cash, upon the exercise, vesting or settlement of all or a portion of any Award may be deferred and may also establish
programs and procedures for deferral elections to be made by Participants. Deferrals will be made in accordance with the requirements
of Section 409A.

 

(n)            Section 409A.
Unless otherwise expressly provided for in an Award Agreement, the Plan and Award Agreements will be interpreted to the greatest
extent possible in a manner that makes the Plan and the Awards granted hereunder exempt from Section 409A, and, to the extent
not so exempt, in compliance with the requirements of Section 409A. If the Board determines that any Award granted hereunder
is not exempt from and is therefore subject to Section 409A, the Award Agreement evidencing such Award will incorporate the
terms and conditions necessary to avoid the consequences specified in Section 409A(a)(1) of the Code, and to the extent
an Award Agreement is silent on terms necessary for compliance, such terms are hereby incorporated by reference into the Award
Agreement. Notwithstanding anything to the contrary in this Plan (and unless the Award Agreement specifically provides otherwise),
if the shares of Common Stock are publicly traded, and if a Participant holding an Award that constitutes “deferred compensation”
under Section 409A is a “specified employee” for purposes of Section 409A, no distribution or payment of
any amount that is due because of a “separation from service” (as defined in Section 409A without regard to alternative
definitions thereunder) will be issued or paid before the date that is six months and one day following the date of such Participant’s
 “separation from service” or, if earlier, the date of the Participant’s death, unless such distribution or payment
can be made in a manner that complies with Section 409A, and any amounts so deferred will be paid in a lump sum on the day
after such six month period elapses, with the balance paid thereafter on the original schedule.

 

(o)            Choice
of Law. This Plan and any controversy arising out of or relating to this Plan shall be governed by, and construed in
accordance with, the internal laws of the State of Delaware, without regard to conflict of law principles that would result in
any application of any law other than the law of the State of Delaware.

 

    15.

     

    

 

10.            Covenants
of the Company.

 

(a)            Compliance
with Law. The Company will seek to obtain from each regulatory commission or agency, as may be deemed to be necessary, having
jurisdiction over the Plan such authority as may be required to grant Awards and to issue and sell shares of Common Stock upon
exercise or vesting of the Awards; provided, however, that this undertaking will not require the Company to register under
the Securities Act the Plan, any Award or any Common Stock issued or issuable pursuant to any such Award. If, after reasonable
efforts and at a reasonable cost, the Company is unable to obtain from any such regulatory commission or agency the authority that
counsel for the Company deems necessary or advisable for the lawful issuance and sale of Common Stock under the Plan, the Company
will be relieved from any liability for failure to issue and sell Common Stock upon exercise or vesting of such Awards unless and
until such authority is obtained. A Participant is not eligible for the grant of an Award or the subsequent issuance of Common
Stock pursuant to the Award if such grant or issuance would be in violation of any Applicable Law.

 

11.            Additional
Rules for Awards Subject to Section 409A.

 

(a)            Application.
 Unless the provisions of this Section of the Plan are expressly superseded by the provisions in the form of Award Agreement,
the provisions of this Section shall apply and shall supersede anything to the contrary set forth in the Award Agreement for
a Non-Exempt Award.

 

(b)            Non-Exempt
Awards Subject to Non-Exempt Severance Arrangements. To the extent a Non-Exempt Award is subject to Section 409A due to
application of a Non-Exempt Severance Arrangement, the following provisions of this subsection (b) apply.

 

(i)            If
the Non-Exempt Award vests in the ordinary course during the Participant’s Continuous Service in accordance with the vesting
schedule set forth in the Award Agreement, and does not accelerate vesting under the terms of a Non-Exempt Severance Arrangement,
in no event will the shares be issued in respect of such Non-Exempt Award any later than the later of: (i) December 31st
of the calendar year that includes the applicable vesting date, or (ii) the 60th day that follows the applicable
vesting date.

 

(ii)           If
vesting of the Non-Exempt Award accelerates under the terms of a Non-Exempt Severance Arrangement in connection with the Participant’s
Separation from Service, and such vesting acceleration provisions were in effect as of the date of grant of the Non-Exempt Award
and, therefore, are part of the terms of such Non-Exempt Award as of the date of grant, then the shares will be earlier issued
in settlement of such Non-Exempt Award upon the Participant’s Separation from Service in accordance with the terms of the
Non-Exempt Severance Arrangement, but in no event later than the 60th day that follows the date of the Participant’s
Separation from Service. However, if at the time the shares would otherwise be issued the Participant is subject to the distribution
limitations contained in Section 409A applicable to “specified employees,” as defined in Section 409A(a)(2)(B)(i) of
the Code, such shares shall not be issued before the date that is six months following the date of such Participant’s Separation
from Service, or, if earlier, the date of the Participant’s death that occurs within such six month period.

 

    16.

     

    

 

(iii)            If
vesting of a Non-Exempt Award accelerates under the terms of a Non-Exempt Severance Arrangement in connection with a Participant’s
Separation from Service, and such vesting acceleration provisions were not in effect as of the date of grant of the Non-Exempt
Award and, therefore, are not a part of the terms of such Non-Exempt Award on the date of grant, then such acceleration of vesting
of the Non-Exempt Award shall not accelerate the issuance date of the shares, but the shares shall instead be issued on the same
schedule as set forth in the Grant Notice as if they had vested in the ordinary course during the Participant’s Continuous
Service, notwithstanding the vesting acceleration of the Non-Exempt Award. Such issuance schedule is intended to satisfy the requirements
of payment on a specified date or pursuant to a fixed schedule, as provided under Treasury Regulations Section 1.409A-3(a)(4).

 

(c)            Treatment
of Non-Exempt Awards Upon a Corporate Transaction for Employees and Consultants. The provisions of this subsection (c) shall
apply and shall supersede anything to the contrary set forth in the Plan with respect to the permitted treatment of any Non-Exempt
Award in connection with a Corporate Transaction if the Participant was either an Employee or Consultant upon the applicable date
of grant of the Non-Exempt Award.

 

(i)            Vested
Non-Exempt Awards. The following provisions shall apply to any Vested Non-Exempt Award in connection with a Corporate Transaction:

 

(1)            If
the Corporate Transaction is also a Section 409A Change in Control then the Acquiring Entity may not assume, continue or substitute
the Vested Non-Exempt Award. Upon the Section 409A Change of Control the settlement of the Vested Non-Exempt Award will automatically
be accelerated and the shares will be immediately issued in respect of the Vested Non-Exempt Award. Alternatively, the Company
may instead provide that the Participant will receive a cash settlement equal to the Fair Market Value of the shares that would
otherwise be issued to the Participant upon the Section 409A Change of Control.

 

(2)            If
the Corporate Transaction is not also a Section 409A Change of Control, then the Acquiring Entity must either assume, continue
or substitute each Vested Non-Exempt Award. The shares to be issued in respect of the Vested Non-Exempt Award shall be issued to
the Participant by the Acquiring Entity on the same schedule that the shares would have been issued to the Participant if the Corporate
Transaction had not occurred. In the Acquiring Entity’s discretion, in lieu of an issuance of shares, the Acquiring Entity
may instead substitute a cash payment on each applicable issuance date, equal to the Fair Market Value of the shares that would
otherwise be issued to the Participant on such issuance dates, with the determination of the Fair Market Value of the shares made
on the date of the Corporate Transaction.

 

(ii)            Unvested
Non-Exempt Awards. The following provisions shall apply to any Unvested Non-Exempt Award unless otherwise determined by the
Board pursuant to subsection (e) of this Section.

 

(1)            In
the event of a Corporate Transaction, the Acquiring Entity shall assume, continue or substitute any Unvested Non-Exempt Award.
Unless otherwise determined by the Board, any Unvested Non-Exempt Award will remain subject to the same vesting and forfeiture
restrictions that were applicable to the Award prior to the Corporate Transaction. The shares to be issued in respect of any Unvested
Non-Exempt Award shall be issued to the Participant by the Acquiring Entity on the same schedule that the shares would have been
issued to the Participant if the Corporate Transaction had not occurred. In the Acquiring Entity’s discretion, in lieu of
an issuance of shares, the Acquiring Entity may instead substitute a cash payment on each applicable issuance date, equal to the
Fair Market Value of the shares that would otherwise be issued to the Participant on such issuance dates, with the determination
of Fair Market Value of the shares made on the date of the Corporate Transaction.

 

    17.

     

    

 

(2)            If
the Acquiring Entity will not assume, substitute or continue any Unvested Non-Exempt Award in connection with a Corporate Transaction,
then such Award shall automatically terminate and be forfeited upon the Corporate Transaction with no consideration payable to
any Participant in respect of such forfeited Unvested Non-Exempt Award. Notwithstanding the foregoing, to the extent permitted
and in compliance with the requirements of Section 409A, the Board may in its discretion determine to elect to accelerate
the vesting and settlement of the Unvested Non-Exempt Award upon the Corporate Transaction, or instead substitute a cash payment
equal to the Fair Market Value of such shares that would otherwise be issued to the Participant, as further provided in subsection
(e)(ii) below. In the absence of such discretionary election by the Board, any Unvested Non-Exempt Award shall be forfeited
without payment of any consideration to the affected Participants if the Acquiring Entity will not assume, substitute or continue
the Unvested Non-Exempt Awards in connection with the Corporate Transaction.

 

(3)            The
foregoing treatment shall apply with respect to all Unvested Non-Exempt Awards upon any Corporate Transaction, and regardless of
whether or not such Corporate Transaction is also a Section 409A Change of Control.

 

(d)            Treatment
of Non-Exempt Awards Upon a Corporate Transaction for Non-Employee Directors. The following provisions of this subsection (d) shall
apply and shall supersede anything to the contrary that may be set forth in the Plan with respect to the permitted treatment of
a Non-Exempt Director Award in connection with a Corporate Transaction.

 

(i)            If
the Corporate Transaction is also a Section 409A Change of Control then the Acquiring Entity may not assume, continue or substitute
the Non-Exempt Director Award. Upon the Section 409A Change of Control the vesting and settlement of any Non-Exempt Director
Award will automatically be accelerated and the shares will be immediately issued to the Participant in respect of the Non-Exempt
Director Award. Alternatively, the Company may provide that the Participant will instead receive a cash settlement equal to the
Fair Market Value of the shares that would otherwise be issued to the Participant upon the Section 409A Change of Control
pursuant to the preceding provision.

 

(ii)            If
the Corporate Transaction is not also a Section 409A Change of Control, then the Acquiring Entity must either assume, continue
or substitute the Non-Exempt Director Award. Unless otherwise determined by the Board, the Non-Exempt Director Award will remain
subject to the same vesting and forfeiture restrictions that were applicable to the Award prior to the Corporate Transaction. The
shares to be issued in respect of the Non-Exempt Director Award shall be issued to the Participant by the Acquiring Entity on the
same schedule that the shares would have been issued to the Participant if the Corporate Transaction had not occurred. In the Acquiring
Entity’s discretion, in lieu of an issuance of shares, the Acquiring Entity may instead substitute a cash payment on each
applicable issuance date, equal to the Fair Market Value of the shares that would otherwise be issued to the Participant on such
issuance dates, with the determination of Fair Market Value made on the date of the Corporate Transaction.

 

(e)            If
the RSU Award is a Non-Exempt Award, then the provisions in this Section 11(e) shall apply and supersede anything to
the contrary that may be set forth in the Plan or the Award Agreement with respect to the permitted treatment of such Non-Exempt
Award:

 

(i)            Any
exercise by the Board of discretion to accelerate the vesting of a Non-Exempt Award shall not result in any acceleration of the
scheduled issuance dates for the shares in respect of the Non-Exempt Award unless earlier issuance of the shares upon the applicable
vesting dates would be in compliance with the requirements of Section 409A.

 

    18.

     

    

 

(ii)            The
Company explicitly reserves the right to earlier settle any Non-Exempt Award to the extent permitted and in compliance with the
requirements of Section 409A, including pursuant to any of the exemptions available in Treasury Regulations Section 1.409A-3(j)(4)(ix).

 

(iii)            To
the extent the terms of any Non-Exempt Award provide that it will be settled upon a Change in Control or Corporate Transaction,
to the extent it is required for compliance with the requirements of Section 409A, the Change in Control or Corporate Transaction
event triggering settlement must also constitute a Section 409A Change of Control. To the extent the terms of a Non-Exempt
Award provides that it will be settled upon a termination of employment or termination of Continuous Service, to the extent it
is required for compliance with the requirements of Section 409A, the termination event triggering settlement must also constitute
a Separation From Service. However, if at the time the shares would otherwise be issued to a Participant in connection with a “separation
from service” such Participant is subject to the distribution limitations contained in Section 409A applicable to “specified
employees,” as defined in Section 409A(a)(2)(B)(i) of the Code, such shares shall not be issued before the date
that is six months following the date of the Participant’s Separation From Service, or, if earlier, the date of the Participant’s
death that occurs within such six month period.

 

(iv)            The
provisions in this subsection (e) for delivery of the shares in respect of the settlement of a RSU Award that is a Non-Exempt
Award are intended to comply with the requirements of Section 409A so that the delivery of the shares to the Participant in
respect of such Non-Exempt Award will not trigger the additional tax imposed under Section 409A, and any ambiguities herein
will be so interpreted.

 

12.            Severability.

 

If all or any part
of the Plan or any Award Agreement is declared by any court or governmental authority to be unlawful or invalid, such unlawfulness
or invalidity shall not invalidate any portion of the Plan or such Award Agreement not declared to be unlawful or invalid. Any
Section of the Plan or any Award Agreement (or part of such a Section) so declared to be unlawful or invalid shall, if possible,
be construed in a manner which will give effect to the terms of such Section or part of a Section to the fullest extent
possible while remaining lawful and valid.

 

13.            Termination
of the Plan.

 

The Board may suspend or terminate the
Plan at any time.

 

No Incentive Stock Options may be granted
after the tenth anniversary of the earlier of: (i) the Adoption Date, or (ii) the date the Plan is approved by the Company’s
stockholders. No Awards may be granted under the Plan while the Plan is suspended or after it is terminated.

 

    19.

     

    

 

14.           Definitions.

 

As used in the Plan,
the following definitions apply to the capitalized terms indicated below:

 

(a)            “Acquiring
Entity” means the surviving or acquiring corporation (or its parent company) in connection with a Corporate Transaction.

 

(b)            Adoption
Date” means the date the Plan is first approved by the Board or Compensation Committee.

 

(c)            “Affiliate”
means, at the time of determination, any “parent” or “subsidiary” of the Company as such terms are defined
in Rule 405 promulgated under the Securities Act. The Board may determine the time or times at which “parent”
or “subsidiary” status is determined within the foregoing definition.

 

(d)            “Applicable
Law” means shall mean any applicable securities, federal, state, foreign, material local or municipal or other law,
statute, constitution, principle of common law, resolution, ordinance, code, edict, decree, rule, listing rule, regulation, judicial
decision, ruling or requirement issued, enacted, adopted, promulgated, implemented or otherwise put into effect by or under the
authority of any Governmental Body (including under the authority of any applicable self-regulating organization such as the Nasdaq
Stock Market, New York Stock Exchange, or the Financial Industry Regulatory Authority).

 

(e)            “Award”
means any right to receive Common Stock, cash or other property granted under the Plan (including an Incentive Stock Option, a
Nonstatutory Stock Option, a Restricted Stock Award, a RSU Award, a SAR, a Performance Award or any Other Award).

 

(f)            “Award
Agreement” means a written agreement between the Company and a Participant evidencing the terms and conditions of
an Award. The Award Agreement generally consists of the Grant Notice and the agreement containing the written summary of the general
terms and conditions applicable to the Award and which is provided to a Participant along with the Grant Notice.

 

(g)            “Board”
means the Board of Directors of the Company (or its designee). Any decision or determination made by the Board shall be a decision
or determination that is made in the sole discretion of the Board (or its designee), and such decision or determination shall be
final and binding on all Participants.

 

(h)            “Capitalization
Adjustment” means any change that is made in, or other events that occur with respect to, the Common Stock subject
to the Plan or subject to any Award after the Effective Date without the receipt of consideration by the Company through merger,
consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than cash, large nonrecurring
cash dividend, stock split, reverse stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate
structure or any similar equity restructuring transaction, as that term is used in Statement of Financial Accounting Standards
Board Accounting Standards Codification Topic 718 (or any successor thereto). Notwithstanding the foregoing, the conversion of
any convertible securities of the Company will not be treated as a Capitalization Adjustment.

 

    20.

     

    

 

(i)            “Cause”
has the meaning ascribed to such term in any written agreement between the Participant and the Company defining such term and,
in the absence of such agreement, such term means, with respect to a Participant, the occurrence of any of the following events:
(i) such Participant’s commission of any crime involving fraud, dishonesty or moral turpitude or attempted commission
of, or participation in, a fraud or act of dishonesty against the Company; (ii) such Participant’s intentional, material
violation of any contract or agreement between the Participant and the Company or of any statutory duty owed to the Company; (iii)  such
Participant’s unauthorized use or disclosure of the Company’s confidential information or trade secrets; or (iv) such
Participant’s gross misconduct, conduct that constitutes gross insubordination, incompetence or habitual neglect of duties
and that results in (or might have reasonably resulted in) material harm to the business of the Company. The determination that
a termination of the Participant’s Continuous Service is either for Cause or without Cause will be made by the Board with
respect to Participants who are executive officers of the Company and by the Company’s Chief Executive Officer with respect
to Participants who are not executive officers of the Company. Any determination by the Company that the Continuous Service of
a Participant was terminated with or without Cause for the purposes of outstanding Awards held by such Participant will have no
effect upon any determination of the rights or obligations of the Company or such Participant for any other purpose.

 

(j)            “Change
in Control” or “Change of Control” means the occurrence, in a single transaction or in
a series of related transactions, of any one or more of the following events; provided, however, to the extent necessary to avoid
adverse personal income tax consequences to the Participant in connection with an Award, also constitutes a Section 409A Change
of Control:

 

(i)            any
Exchange Act Person becomes the Owner, directly or indirectly, of securities of the Company representing more than 50% of the combined
voting power of the Company’s then outstanding securities other than by virtue of a merger, consolidation or similar transaction.
Notwithstanding the foregoing, a Change in Control shall not be deemed to occur (A) on account of the acquisition of securities
of the Company directly from the Company, (B) on account of the acquisition of securities of the Company by an investor, any
affiliate thereof or any other Exchange Act Person that acquires the Company’s securities in a transaction or series of related
transactions the primary purpose of which is to obtain financing for the Company through the issuance of equity securities, or
(C) solely because the level of Ownership held by any Exchange Act Person (the “Subject Person”) exceeds
the designated percentage threshold of the outstanding voting securities as a result of a repurchase or other acquisition of voting
securities by the Company reducing the number of shares outstanding, provided that if a Change in Control would occur (but for
the operation of this sentence) as a result of the acquisition of voting securities by the Company, and after such share acquisition,
the Subject Person becomes the Owner of any additional voting securities that, assuming the repurchase or other acquisition had
not occurred, increases the percentage of the then outstanding voting securities Owned by the Subject Person over the designated
percentage threshold, then a Change in Control shall be deemed to occur;

 

(ii)            there
is consummated a merger, consolidation or similar transaction involving (directly or indirectly) the Company and, immediately after
the consummation of such merger, consolidation or similar transaction, the stockholders of the Company immediately prior thereto
do not Own, directly or indirectly, either (A) outstanding voting securities representing more than 50% of the combined outstanding
voting power of the surviving Entity in such merger, consolidation or similar transaction or (B) more than 50% of the combined
outstanding voting power of the parent of the surviving Entity in such merger, consolidation or similar transaction, in each case
in substantially the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior
to such transaction;

 

(iii)            the
stockholders of the Company approve or the Board approves a plan of complete dissolution or liquidation of the Company, or a complete
dissolution or liquidation of the Company shall otherwise occur, except for a liquidation into a parent corporation;

 

    21.

     

    

 

(iv)            there
is consummated a sale, lease, exclusive license or other disposition of all or substantially all of the consolidated assets of
the Company and its Subsidiaries, other than a sale, lease, license or other disposition of all or substantially all of the consolidated
assets of the Company and its Subsidiaries to an Entity, more than 50% of the combined voting power of the voting securities of
which are Owned by stockholders of the Company in substantially the same proportions as their Ownership of the outstanding voting
securities of the Company immediately prior to such sale, lease, license or other disposition; or

 

(v)            individuals
who, on the date the Plan is adopted by the Board, are members of the Board (the “Incumbent Board”) cease
for any reason to constitute at least a majority of the members of the Board; provided, however, that if the appointment
or election (or nomination for election) of any new Board member was approved or recommended by a majority vote of the members
of the Incumbent Board then still in office, such new member shall, for purposes of this Plan, be considered as a member of the
Incumbent Board.

 

Notwithstanding the
foregoing or any other provision of this Plan, (A) the term Change in Control shall not include a sale of assets, merger or
other transaction effected exclusively for the purpose of changing the domicile of the Company, and (B) the definition of
Change in Control (or any analogous term) in an individual written agreement between the Company or any Affiliate and the Participant
shall supersede the foregoing definition with respect to Awards subject to such agreement; provided, however, that if no
definition of Change in Control or any analogous term is set forth in such an individual written agreement, the foregoing definition
shall apply.

 

(k)           “Code”
means the Internal Revenue Code of 1986, as amended, including any applicable regulations and guidance thereunder.

 

(l)            “Committee”
means the Compensation Committee and any other committee of Directors to whom authority has been delegated by the Board or Compensation
Committee in accordance with the Plan.

 

(m)          “Common
Stock” means the common stock of the Company.

 

(n)           “Company”
means Immunome, Inc., a Delaware corporation.

 

(o)           “Compensation
Committee” means the Compensation Committee of the Board.

 

(p)            “Consultant”
means any person, including an advisor, who is (i) engaged by the Company or an Affiliate to render consulting or advisory
services and is compensated for such services, or (ii) serving as a member of the board of directors of an Affiliate and is
compensated for such services. However, service solely as a Director, or payment of a fee for such service, will not cause a Director
to be considered a “Consultant” for purposes of the Plan. Notwithstanding the foregoing, a person is treated as a Consultant
under this Plan only if a Form S-8 Registration Statement under the Securities Act is available to register either the offer
or the sale of the Company’s securities to such person.

 

    22.

     

    

 

(q)            “Continuous
Service” means that the Participant’s service with the Company or an Affiliate, whether as an Employee, Director
or Consultant, is not interrupted or terminated. A change in the capacity in which the Participant renders service to the Company
or an Affiliate as an Employee, Director or Consultant or a change in the Entity for which the Participant renders such service,
provided that there is no interruption or termination of the Participant’s service with the Company or an Affiliate, will
not terminate a Participant’s Continuous Service; provided, however, that if the Entity for which a Participant is
rendering services ceases to qualify as an Affiliate, as determined by the Board, such Participant’s Continuous Service will
be considered to have terminated on the date such Entity ceases to qualify as an Affiliate. For example, a change in status from
an Employee of the Company to a Consultant of an Affiliate or to a Director will not constitute an interruption of Continuous Service.
To the extent permitted by law, the Board or the chief executive officer of the Company, in that party’s sole discretion,
may determine whether Continuous Service will be considered interrupted in the case of (i) any leave of absence approved by
the Board or chief executive officer, including sick leave, military leave or any other personal leave, or (ii) transfers
between the Company, an Affiliate, or their successors. Notwithstanding the foregoing, a leave of absence will be treated as Continuous
Service for purposes of vesting in an Award only to such extent as may be provided in the Company’s leave of absence policy,
in the written terms of any leave of absence agreement or policy applicable to the Participant, or as otherwise required by law.
In addition, to the extent required for exemption from or compliance with Section 409A, the determination of whether there
has been a termination of Continuous Service will be made, and such term will be construed, in a manner that is consistent with
the definition of “separation from service” as defined under Treasury Regulation Section 1.409A-1(h) (without
regard to any alternative definition thereunder).

 

(r)            “Corporate
Transaction” means the consummation, in a single transaction or in a series of related transactions, of any one or
more of the following events:

 

(i)            a
sale or other disposition of all or substantially all, as determined by the Board, of the consolidated assets of the Company and
its Subsidiaries;

 

(ii)           a
sale or other disposition of at least 50% of the outstanding securities of the Company;

 

(iii)          a
merger, consolidation or similar transaction following which the Company is not the surviving corporation; or

 

(iv)          a
merger, consolidation or similar transaction following which the Company is the surviving corporation but the shares of Common
Stock outstanding immediately preceding the merger, consolidation or similar transaction are converted or exchanged by virtue of
the merger, consolidation or similar transaction into other property, whether in the form of securities, cash or otherwise.

 

(s)            “Director”
means a member of the Board.

 

(t)            “determine”
or “determined” means as determined by the Board or the Committee (or its designee) in its sole discretion.

 

(u)            “Disability”
means, with respect to a Participant, such Participant is unable to engage in any substantial gainful activity by reason of any
medically determinable physical or mental impairment which can be expected to result in death or which has lasted or can be expected
to last for a continuous period of not less than 12 months, as provided in Section 22(e)(3) of the Code, and will be
determined by the Board on the basis of such medical evidence as the Board deems warranted under the circumstances.

 

(v)            “Effective
Date” means the IPO Date, provided this Plan is approved by the Company’s stockholders prior to the IPO Date.

 

(w)            “Employee”
means any person employed by the Company or an Affiliate. However, service solely as a Director, or payment of a fee for such services,
will not cause a Director to be considered an “Employee” for purposes of the Plan.

 

    23.

     

    

 

(x)            “Employer”
means the Company or the Affiliate of the Company that employs the Participant.

 

(y)            “Entity”
means a corporation, partnership, limited liability company or other entity.

 

(z)            “Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

(aa)          “Exchange
Act Person” means any natural person, Entity or “group” (within the meaning of Section 13(d) or
14(d) of the Exchange Act), except that “Exchange Act Person” will not include (i) the Company or any Subsidiary
of the Company, (ii) any employee benefit plan of the Company or any Subsidiary of the Company or any trustee or other fiduciary
holding securities under an employee benefit plan of the Company or any Subsidiary of the Company, (iii) an underwriter temporarily
holding securities pursuant to a registered public offering of such securities, (iv) an Entity Owned, directly or indirectly,
by the stockholders of the Company in substantially the same proportions as their Ownership of stock of the Company; or (v) any
natural person, Entity or “group” (within the meaning of Section 13(d) or 14(d) of the Exchange Act)
that, as of the Effective Date, is the Owner, directly or indirectly, of securities of the Company representing more than 50% of
the combined voting power of the Company’s then outstanding securities.

 

(bb)          “Fair
Market Value” means, as of any date, unless otherwise determined by the Board, the value of the Common Stock (as
determined on a per share or aggregate basis, as applicable) determined as follows:

 

(i)            If
the Common Stock is listed on any established stock exchange or traded on any established market, the Fair Market Value will be
the closing sales price for such stock as quoted on such exchange or market (or the exchange or market with the greatest volume
of trading in the Common Stock) on the date of determination, as reported in a source the Board deems reliable.

 

(ii)           If
there is no closing sales price for the Common Stock on the date of determination, then the Fair Market Value will be the closing
selling price on the last preceding date for which such quotation exists.

 

(iii)         In
the absence of such markets for the Common Stock, or if otherwise determined by the Board, the Fair Market Value will be determined
by the Board in good faith and in a manner that complies with Sections 409A and 422 of the Code.

 

(cc)          “Governmental
Body” means any: (a) nation, state, commonwealth, province, territory, county, municipality, district or other
jurisdiction of any nature; (b) federal, state, local, municipal, foreign or other government; (c) governmental or regulatory
body, or quasi-governmental body of any nature (including any governmental division, department, administrative agency or bureau,
commission, authority, instrumentality, official, ministry, fund, foundation, center, organization, unit, body or Entity and any
court or other tribunal, and for the avoidance of doubt, any Tax authority) or other body exercising similar powers or authority;
or (d) self-regulatory organization (including the Nasdaq Stock Market, New York Stock Exchange, and the Financial Industry
Regulatory Authority).

 

(dd)          “Grant
Notice” means the notice provided to a Participant that he or she has been granted an Award under the Plan and which
includes the name of the Participant, the type of Award, the date of grant of the Award, number of shares of Common Stock subject
to the Award or potential cash payment right, (if any), the vesting schedule for the Award (if any) and other key terms applicable
to the Award.

 

    24.

     

    

 

(ee)          “Incentive
Stock Option” means an option granted pursuant to Section 4 of the Plan that is intended to be, and qualifies
as, an “incentive stock option” within the meaning of Section 422 of the Code.

 

(ff)           “IPO
Date” means the date of the underwriting agreement between the Company and the underwriter(s) managing the initial
public offering of the Common Stock, pursuant to which the Common Stock is priced for the initial public offering.

 

(gg)         “Materially
Impair” means any amendment to the terms of the Award that materially adversely affects the Participant’s rights
under the Award. A Participant's rights under an Award will not be deemed to have been Materially Impaired by any such amendment
if the Board, in its sole discretion, determines that the amendment, taken as a whole, does not materially impair the Participant's
rights. For example, the following types of amendments to the terms of an Award do not Materially Impair the Participant’s
rights under the Award: (i) imposition of reasonable restrictions on the minimum number of shares subject to an Option that
may be exercised, (ii) to maintain the qualified status of the Award as an Incentive Stock Option under Section 422 of
the Code; (iii) to change the terms of an Incentive Stock Option in a manner that disqualifies, impairs or otherwise affects
the qualified status of the Award as an Incentive Stock Option under Section 422 of the Code; (iv) to clarify the manner
of exemption from, or to bring the Award into compliance with or qualify it for an exemption from, Section 409A; or (v) to
comply with other Applicable Laws.

 

(hh)         “Non-Employee
Director” means a Director who either (i) is not a current employee or officer of the Company or an Affiliate,
does not receive compensation, either directly or indirectly, from the Company or an Affiliate for services rendered as a consultant
or in any capacity other than as a Director (except for an amount as to which disclosure would not be required under Item 404(a) of
Regulation S-K promulgated pursuant to the Securities Act (“Regulation S-K”)), does not possess an interest
in any other transaction for which disclosure would be required under Item 404(a) of Regulation S-K, and is not engaged in
a business relationship for which disclosure would be required pursuant to Item 404(b) of Regulation S-K; or (ii) is
otherwise considered a “non-employee director” for purposes of Rule 16b-3.

 

(ii)           “Non-Exempt
Award” means any Award that is subject to, and not exempt from, Section 409A, including as the result of (i) a
deferral of the issuance of the shares subject to the Award which is elected by the Participant or imposed by the Company, (ii) the
terms of any Non-Exempt Severance Agreement.

 

(jj)           “Non-Exempt
Director Award” means a Non-Exempt Award granted to a Participant who was a Director but not an Employee on the applicable
grant date.

 

(kk)        “Non-Exempt
Severance Arrangement” means a severance arrangement or other agreement between the Participant and the Company that
provides for acceleration of vesting of an Award and issuance of the shares in respect of such Award upon the Participant’s
termination of employment or separation from service (as such term is defined in Section 409A(a)(2)(A)(i) of the Code
(and without regard to any alternative definition thereunder) (“Separation from Service”)) and such severance
benefit does not satisfy the requirements for an exemption from application of Section 409A provided under Treasury Regulations
Section 1.409A-1(b)(4), 1.409A-1(b)(9) or otherwise.

 

(ll)           “Nonstatutory
Stock Option” means any option granted pursuant to Section 4 of the Plan that does not qualify as an Incentive
Stock Option.

 

    25.

     

    

 

(mm)       “Officer”
means a person who is an officer of the Company within the meaning of Section 16 of the Exchange Act.

 

(nn)         “Option”
means an Incentive Stock Option or a Nonstatutory Stock Option to purchase shares of Common Stock granted pursuant to the Plan.

 

(oo)          “Option
Agreement” means a written agreement between the Company and the Optionholder evidencing the terms and conditions
of the Option grant. The Option Agreement includes the Grant Notice for the Option and the agreement containing the written summary
of the general terms and conditions applicable to the Option and which is provided to a Participant along with the Grant Notice.
Each Option Agreement will be subject to the terms and conditions of the Plan.

 

(pp)          “Optionholder”
means a person to whom an Option is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding
Option.

 

(qq)          “Other
Award” means an award based in whole or in part by reference to the Common Stock which is granted pursuant to the
terms and conditions of Section 5(c).

 

(rr)          “Other
Award Agreement” means a written agreement between the Company and a holder of an Other Award evidencing the terms
and conditions of an Other Award grant. Each Other Award Agreement will be subject to the terms and conditions of the Plan.

 

(ss)          “Own,”
 “Owned,” “Owner,” “Ownership” means that a person
or Entity will be deemed to “Own,” to have “Owned,” to be the “Owner” of, or to have acquired
 “Ownership” of securities if such person or Entity, directly or indirectly, through any contract, arrangement, understanding,
relationship or otherwise, has or shares voting power, which includes the power to vote or to direct the voting, with respect to
such securities.

 

(tt)           “Participant”
means an Employee, Director or Consultant to whom an Award is granted pursuant to the Plan or, if applicable, such other person
who holds an outstanding Award.

 

(uu)         “Performance
Award” means an Award that may vest or may be exercised or a cash award that may vest or become earned and paid contingent
upon the attainment during a Performance Period of certain Performance Goals and which is granted under the terms and conditions
of Section 5(b) pursuant to such terms as are approved by the Board. In addition, to the extent permitted by Applicable
Law and set forth in the applicable Award Agreement, the Board may determine that cash or other property may be used in payment
of Performance Awards. Performance Awards that are settled in cash or other property are not required to be valued in whole or
in part by reference to, or otherwise based on, the Common Stock.

 

(vv)          “Performance
Criteria” means the one or more criteria that the Board will select for purposes of establishing the Performance
Goals for a Performance Period. The Performance Criteria that will be used to establish such Performance Goals may be based on
any measure of performance selected by the Board.

 

    26.

     

    

 

(ww)        “Performance
Goals” means, for a Performance Period, the one or more goals established by the Board for the Performance Period
based upon the Performance Criteria. Performance Goals may be based on a Company-wide basis, with respect to one or more business
units, divisions, Affiliates, or business segments, and in either absolute terms or relative to the performance of one or more
comparable companies or the performance of one or more relevant indices. Unless specified otherwise by the Board (i) in the
Award Agreement at the time the Award is granted or (ii) in such other document setting forth the Performance Goals at the
time the Performance Goals are established, the Board will appropriately make adjustments in the method of calculating the attainment
of Performance Goals for a Performance Period as follows: (1) to exclude restructuring and/or other nonrecurring charges;
(2) to exclude exchange rate effects; (3) to exclude the effects of changes to generally accepted accounting principles;
(4) to exclude the effects of any statutory adjustments to corporate tax rates; (5) to exclude the effects of items that
are “unusual” in nature or occur “infrequently” as determined under generally accepted accounting principles;
(6) to exclude the dilutive effects of acquisitions or joint ventures; (7) to assume that any business divested by the
Company achieved performance objectives at targeted levels during the balance of a Performance Period following such divestiture;
(8) to exclude the effect of any change in the outstanding shares of common stock of the Company by reason of any stock dividend
or split, stock repurchase, reorganization, recapitalization, merger, consolidation, spin-off, combination or exchange of shares
or other similar corporate change, or any distributions to common stockholders other than regular cash dividends; (9) to exclude
the effects of stock based compensation and the award of bonuses under the Company’s bonus plans; (10) to exclude costs
incurred in connection with potential acquisitions or divestitures that are required to expensed under generally accepted accounting
principles; and (11) to exclude the goodwill and intangible asset impairment charges that are required to be recorded under generally
accepted accounting principles. In addition, the Board retains the discretion to reduce or eliminate the compensation or economic
benefit due upon attainment of Performance Goals and to define the manner of calculating the Performance Criteria it selects to
use for such Performance Period. Partial achievement of the specified criteria may result in the payment or vesting corresponding
to the degree of achievement as specified in the Award Agreement or the written terms of a Performance Cash Award.

 

(xx)          “Performance
Period” means the period of time selected by the Board over which the attainment of one or more Performance Goals
will be measured for the purpose of determining a Participant’s right to vesting or exercise of an Award. Performance Periods
may be of varying and overlapping duration, at the sole discretion of the Board.

 

(yy)          “Plan”
means this Immunome, Inc. 2020 Equity Incentive Plan, as amended from time to time.

 

(zz)          “Plan
Administrator” means the person, persons, and/or third-party administrator designated by the Company to administer
the day to day operations of the Plan and the Company’s other equity incentive programs.

 

(aaa)        “Post-Termination
Exercise Period” means the period following termination of a Participant’s Continuous Service within which
an Option or SAR is exercisable, as specified in Section 4(h).

 

(bbb)        “Prior
Plans’ Available Reserve” means the number of shares available for the grant of new awards under the Prior
Plans, to the extent applicable, as of immediately prior to the Effective Date.

 

(ccc)        “Prior
Plans” mean the Immunome, Inc. 2018 Equity Incentive Plan and the Immunome, Inc. 2008 Equity Incentive
Plan, each as amended.

 

(ddd)        “Prospectus”
means the document containing the Plan information specified in Section 10(a) of the Securities Act.

 

(eee)        “Restricted
Stock Award” or “RSA” means an Award of shares of Common Stock which is granted pursuant
to the terms and conditions of Section 5(a).

 

    27.

     

    

 

(fff)          “Restricted
Stock Award Agreement” means a written agreement between the Company and a holder of a Restricted Stock Award evidencing
the terms and conditions of a Restricted Stock Award grant. The Restricted Stock Award Agreement includes the Grant Notice for
the Restricted Stock Award and the agreement containing the written summary of the general terms and conditions applicable to the
Restricted Stock Award and which is provided to a Participant along with the Grant Notice. Each Restricted Stock Award Agreement
will be subject to the terms and conditions of the Plan.

 

(ggg)       “Returning
Shares” means shares subject to outstanding stock awards granted under the Prior Plans and that following the Effective
Date: (A)  are not issued because such stock award or any portion thereof expires or otherwise terminates without all of the
shares covered by such stock award having been issued; (B)  are not issued because such stock award or any portion thereof
is settled in cash; (C)  are forfeited back to or repurchased by the Company because of the failure to meet a contingency
or condition required for the vesting of such shares; (D) are withheld or reacquired to satisfy the exercise, strike or purchase
price; or (E) are withheld or reacquired to satisfy a tax withholding obligation.

 

(hhh)       “RSU
Award” or “RSU” means an Award of restricted stock units representing the right to receive
an issuance of shares of Common Stock which is granted pursuant to the terms and conditions of Section 5(a).

 

(iii)          “RSU
Award Agreement” means a written agreement between the Company and a holder of a RSU Award evidencing the terms and
conditions of a RSU Award grant. The RSU Award Agreement includes the Grant Notice for the RSU Award and the agreement containing
the written summary of the general terms and conditions applicable to the RSU Award and which is provided to a Participant along
with the Grant Notice. Each RSU Award Agreement will be subject to the terms and conditions of the Plan.

 

(jjj)          “Rule 16b-3”
means Rule 16b-3 promulgated under the Exchange Act or any successor to Rule 16b-3, as in effect from time to time.

 

(kkk)      “Rule 405”
means Rule 405 promulgated under the Securities Act.

 

(lll)          “Section 409A”
means Section 409A of the Code and the regulations and other guidance thereunder.

 

(mmm)    “Section 409A
Change of Control” means a change in the ownership or effective control of the Company, or in the ownership of a
substantial portion of the Company’s assets, as provided in Section 409A(a)(2)(A)(v) of the Code and Treasury Regulations
Section 1.409A-3(i)(5) (without regard to any alternative definition thereunder).

 

(nnn)       “Securities
Act” means the Securities Act of 1933, as amended.

 

(ooo)        “Share
Reserve” means the number of shares available for issuance under the Plan as set forth in Section 2(a).

 

(ppp)        “Stock
Appreciation Right” or “SAR” means a right to receive the appreciation on Common Stock
that is granted pursuant to the terms and conditions of Section 4.

 

(qqq)        “SAR
Agreement” means a written agreement between the Company and a holder of a SAR evidencing the terms and conditions
of a SAR grant. The SAR Agreement includes the Grant Notice for the SAR and the agreement containing the written summary of the
general terms and conditions applicable to the SAR and which is provided to a Participant along with the Grant Notice. Each SAR
Agreement will be subject to the terms and conditions of the Plan.

 

    28.

     

    

 

(rrr)        “Subsidiary”
means, with respect to the Company, (i) any corporation of which more than 50% of the outstanding capital stock having ordinary
voting power to elect a majority of the board of directors of such corporation (irrespective of whether, at the time, stock of
any other class or classes of such corporation will have or might have voting power by reason of the happening of any contingency)
is at the time, directly or indirectly, Owned by the Company, and (ii) any partnership, limited liability company or other
entity in which the Company has a direct or indirect interest (whether in the form of voting or participation in profits or capital
contribution) of more than 50%.

 

(sss)        “Ten
Percent Stockholder” means a person who Owns (or is deemed to Own pursuant to Section 424(d) of the Code)
stock possessing more than 10% of the total combined voting power of all classes of stock of the Company or any Affiliate.

 

(ttt)         “Trading
Policy” means the Company’s policy permitting certain individuals to sell Company shares only during certain
 "window" periods and/or otherwise restricts the ability of certain individuals to transfer or encumber Company shares,
as in effect from time to time.

 

(uuu)      “Unvested
Non-Exempt Award” means the portion of any Non-Exempt Award that had not vested in accordance with its terms upon
or prior to the date of any Corporate Transaction.

 

(vvv)       “Vested
Non-Exempt Award” means the portion of any Non-Exempt Award that had vested in accordance with its terms upon or
prior to the date of a Corporate Transaction.

 

    29.Exhibit
10.7 

 

Immunome, Inc.

Stock Option Grant Notice

(2020 Equity Incentive Plan)

 

Immunome, Inc. (the “Company”),
pursuant to its 2020 Equity Incentive Plan (the “Plan”), has granted to you (“Optionholder”)
an option to purchase the number of shares of the Common Stock set forth below (the “Option”). Your Option
is subject to all of the terms and conditions as set forth herein and in the Plan, and the Stock Option Agreement and the Notice
of Exercise, all of which are attached hereto and incorporated herein in their entirety. Capitalized terms not explicitly defined
herein but defined in the Plan or the Stock Option Agreement shall have the meanings set forth in the Plan or the Stock Option
Agreement, as applicable.

 

	Optionholder:	 
	Date of Grant:	 
	Vesting Commencement Date:	 
	Number of Shares of Common Stock Subject to Option:	 
	Exercise Price (Per Share):	 
	Total Exercise Price:	 
	Expiration Date:	 

 

	Type of Grant:	[Incentive
Stock Option] OR [Nonstatutory Stock Option]
	 	 
	Exercise
and Vesting
Schedule:	Subject
to the Optionholder’s Continuous Service through each applicable vesting date, the Option will vest as follows:
	 	 
	 	1/4th of the shares
vest and become exercisable one year after the Vesting Commencement Date; the balance of the shares vest and become exercisable
in a series of thirty-six (36) successive equal monthly installments measured from the first anniversary of the Vesting Commencement
Date on the same date of the month as the Vesting Commencement Date. [Notwithstanding the foregoing, the Option will accelerate
vesting and exercisability in full upon a Change in Control which occurs during your Continuous Service.]

 

Optionholder Acknowledgements: By
your signature below or by electronic acceptance or authentication in a form authorized by the Company, you understand and agree
that:

 

		·	The Option is governed by this Stock Option Grant Notice, and the provisions of the Plan and the
Stock Option Agreement and the Notice of Exercise, all of which are made a part of this document. Unless otherwise provided in
the Plan, this Grant Notice and the Stock Option Agreement (together, the “Option Agreement”) may not
be modified, amended or revised except in a writing signed by you and a duly authorized officer of the Company.

 

		·	[If the Option is an Incentive Stock Option, it (plus other outstanding Incentive Stock Options
granted to you) cannot be first exercisable for more than $100,000 in value (measured by exercise price) in any calendar
year. Any excess over $100,000 is a Nonstatutory Stock Option.]

 

		·	You consent to receive this Grant Notice, the Stock Option Agreement, the Plan, the Prospectus
and any other Plan-related documents by electronic delivery and to participate in the Plan through an on-line or electronic system
established and maintained by the Company or another third party designated by the Company.

 

    1.

     

    

 

		·	You have read and are familiar with the provisions of the Plan, the Stock Option Agreement, the
Notice of Exercise and the Prospectus. In the event of any conflict between the provisions in this Grant Notice, the Option Agreement,
the Notice of Exercise, or the Prospectus and the terms of the Plan, the terms of the Plan shall control.

 

		·	The Option Agreement sets forth the entire understanding between you and the Company regarding
the acquisition of Common Stock and supersedes all prior oral and written agreements, promises and/or representations on that subject
with the exception of other equity awards previously granted to you and any written employment agreement, offer letter, severance
agreement, written severance plan or policy, or other written agreement between the Company and you in each case that specifies
the terms that should govern this Option.

 

		·	Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic signature
complying with the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act or other applicable law) or other transmission
method and any counterpart so delivered will be deemed to have been duly and validly delivered and be valid and effective for all
purposes.

 

	Immunome, Inc.	 	Optionholder:
	 	 	 	 
	By:	 	 	 
	 	Signature	 	Signature
	Title:	 	 	Date:	                 
	 	 	 	 	 
	Date:	 	 	 

 

Attachments:
Stock Option Agreement, 2020 Equity Incentive Plan, Notice of Exercise

 

    

     

    

 

Attachment
I

 

Stock
Option Agreement

 

    

     

    

 

Attachment
II

 

2020
Equity Incentive Plan

 

    

     

    

 

Attachment
III

 

Notice
of Exercise

 

    

     

    

 

Immunome, Inc.

2020 Equity Incentive Plan

 

Stock
Option Agreement

 

As reflected by your
Stock Option Grant Notice (“Grant Notice”), Immunome, Inc. (the “Company”)
has granted you an option under its 2020 Equity Incentive Plan (the “Plan”) to purchase a number of shares
of Common Stock at the exercise price indicated in your Grant Notice (the “Option”). Capitalized terms
not explicitly defined in this Agreement but defined in the Grant Notice or the Plan shall have the meanings set forth in the Grant
Notice or Plan, as applicable. The terms of your Option as specified in the Grant Notice and this Stock Option Agreement constitute
your Option Agreement.

 

The general terms and
conditions applicable to your Option are as follows:

 

1.            Governing
Plan Document. Your Option is subject to all the provisions of the Plan, including but
not limited to the provisions in:

 

(a)          Section 6
regarding the impact of a Capitalization Adjustment, dissolution, liquidation, or Corporate Transaction on your Option;

 

(b)          Section 9(e) regarding
the Company’s retained rights to terminate your Continuous Service notwithstanding the grant of the Option; and

 

(c)          Section 8(c) regarding
the tax consequences of your Option.

 

Your Option is further subject to all interpretations,
amendments, rules and regulations, which may from time to time be promulgated and adopted pursuant to the Plan. In the event
of any conflict between the Option Agreement and the provisions of the Plan, the provisions of the Plan shall control.

 

2.            Exercise.

 

(a)          You
may generally exercise the vested portion of your Option for whole shares of Common Stock at any time during its term by delivery
of payment of the exercise price and applicable withholding taxes and other required documentation to the Plan Administrator in
accordance with the exercise procedures established by the Plan Administrator, which may include an electronic submission. Please
review Sections 4(i), 4(j) and 7(b)(v) of the Plan, which may restrict or prohibit your ability to exercise your Option
during certain periods.

 

(b)          To
the extent permitted by Applicable Law, you may pay your Option exercise price as follows:

 

(i)           cash,
check, bank draft or money order;

 

    

     

    

 

(ii)          subject
to Company and/or Committee consent at the time of exercise, pursuant to a “cashless exercise” program as further described
in Section 4(c)(ii) of the Plan if at the time of exercise the Common Stock is publicly traded;

 

(iii)        subject
to Company and/or Committee consent at the time of exercise, by delivery of previously owned shares of Common Stock as further
described in Section 4(c)(iii) of the Plan; or

 

(iv)         subject
to Company and/or Committee consent at the time of exercise, if the Option is a Nonstatutory Stock Option, by a “net exercise”
arrangement as further described in Section 4(c)(iv) of the Plan.

 

(c)          By
accepting your Option, you agree that you will not sell, dispose of, transfer, make any short sale of, grant any option for the
purchase of, or enter into any hedging or similar transaction with the same economic effect as a sale with respect to any shares
of Common Stock or other securities of the Company held by you, for a period of one hundred eighty (180) days following the effective
date of a registration statement of the Company filed under the Securities Act or such longer period as the underwriters or the
Company will request to facilitate compliance with FINRA Rule 2241 or any successor or similar rules or regulation(the
 “Lock-Up Period”); provided, however, that nothing contained in this section will prevent the
exercise of a repurchase option, if any, in favor of the Company during the Lock-Up Period. You further agree to execute and deliver
such other agreements as may be reasonably requested by the Company or the underwriters that are consistent with the foregoing
or that are necessary to give further effect thereto. In order to enforce the foregoing covenant, the Company may impose stop-transfer
instructions with respect to your shares of Common Stock until the end of such period. You also agree that any transferee of any
shares of Common Stock (or other securities) of the Company held by you will be bound by this Section 2(c). The underwriters
of the Company’s stock are intended third party beneficiaries of this Section 2(c) and will have the right, power
and authority to enforce the provisions hereof as though they were a party hereto.

 

3.            Term.
You may not exercise your Option before the commencement of its term or after its term expires. The
term of your Option commences on the Date of Grant and expires upon the earliest of the following:

 

(a)          immediately
upon the termination of your Continuous Service for Cause;

 

(b)          three
months after the termination of your Continuous Service for any reason other than Cause, Disability or death;

 

(c)          12
months after the termination of your Continuous Service due to your Disability;

 

(d)          24
months after your death if you die during your Continuous Service;

 

(e)          immediately
upon a Corporate Transaction if the Board has determined that the Option will terminate in connection with a Corporate Transaction,

 

(f)           the
Expiration Date indicated in your Grant Notice; or

 

    2.

     

    

 

(g)          the
day before the 10th anniversary of the Date of Grant.

 

Notwithstanding the
foregoing, if you die during the period provided in Section 3(b) or 3(c) above, the term of your Option shall not
expire until the earlier of (i) 24 months after your death, (ii) upon any termination of the Option in connection with
a Corporate Transaction, (iii) the Expiration Date indicated in your Grant Notice, or (iv) the day before the tenth anniversary
of the Date of Grant. Additionally, the Post-Termination Exercise Period of your Option may be extended as provided in Section 4(i) of
the Plan.

 

To obtain the federal
income tax advantages associated with an Incentive Stock Option, the Code requires that at all times beginning on the date of grant
of your Option and ending on the day three months before the date of your Option’s exercise, you must be an employee of the
Company or an Affiliate, except in the event of your death or Disability. If the Company provides for the extended exercisability
of your Option under certain circumstances for your benefit, your Option will not necessarily be treated as an Incentive Stock
Option if you exercise your Option more than three months after the date your employment terminates.

 

4.            Withholding
Obligations. As further provided in Section 8 of the Plan: (a) you may not exercise
your Option unless the applicable tax withholding obligations are satisfied, and (b) at the time you exercise your Option,
in whole or in part, or at any time thereafter as requested by the Company, you hereby authorize withholding from payroll and any
other amounts payable to you, and otherwise agree to make adequate provision for (including by means of a “cashless exercise”
pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board to the extent permitted by the Company),
any sums required to satisfy the federal, state, local and foreign tax withholding obligations, if any, which arise in connection
with the exercise of your Option in accordance with the withholding procedures established by the Company. Accordingly, you may
not be able to exercise your Option even though the Option is vested, and the Company shall have no obligation to issue shares
of Common Stock subject to your Option, unless and until such obligations are satisfied. In the event that the amount of the Company’s
withholding obligation in connection with your Option was greater than the amount actually withheld by the Company, you agree to
indemnify and hold the Company harmless from any failure by the Company to withhold the proper amount.

 

5.            Incentive
Stock Option Disposition Requirement. If your Option is an Incentive Stock Option, you
must notify the Company in writing within 15 days after the date of any disposition of any of the shares of the Common Stock issued
upon exercise of your Option that occurs within two years after the date of your Option grant or within one year after such shares
of Common Stock are transferred upon exercise of your Option.

 

6.            Transferability.
Except as otherwise provided in Section 4(e) of the Plan, your Option is not transferable,
except by will or by the applicable laws of descent and distribution, and is exercisable during your life only by you.

 

7.            Corporate
Transaction. Your Option is subject to the terms of any agreement governing a Corporate
Transaction involving the Company, including, without limitation, a provision for the appointment of a stockholder representative
that is authorized to act on your behalf with respect to any escrow, indemnities and any contingent consideration.

 

    3.

     

    

 

8.            No
Liability for Taxes. As a condition to accepting
the Option, you hereby (a) agree to not make any claim against the Company, or any of its Officers, Directors, Employees or
Affiliates related to tax liabilities arising from the Option or other Company compensation and (b) acknowledge that you were
advised to consult with your own personal tax, financial and other legal advisors regarding the tax consequences of the Option
and have either done so or knowingly and voluntarily declined to do so. Additionally, you acknowledge that the Option is exempt
from Section 409A only if the exercise price is at least equal to the “fair market value” of the Common Stock
on the date of grant as determined by the Internal Revenue Service and there is no other impermissible deferral of compensation
associated with the Option. Additionally, as a condition to accepting the Option, you agree not make any claim against the Company,
or any of its Officers, Directors, Employees or Affiliates in the event that the Internal Revenue Service asserts that such exercise
is less than the “fair market value” of the Common Stock on the date of grant as subsequently determined by the Internal
Revenue Service.

 

9.           Severability.
If any part of this Option Agreement or the Plan is declared by any court or governmental authority to be unlawful or invalid,
such unlawfulness or invalidity will not invalidate any portion of this Option Agreement or the Plan not declared to be unlawful
or invalid.  Any Section of this Option Agreement (or part of such a Section) so declared to be unlawful or invalid
will, if possible, be construed in a manner which will give effect to the terms of such Section or part of a Section to
the fullest extent possible while remaining lawful and valid

 

10.         Other
Documents.  You hereby acknowledge receipt of or the right to receive a document
providing the information required by Rule 428(b)(1) promulgated under the Securities Act, which includes the Prospectus.  In
addition, you acknowledge receipt of the Company’s Trading Policy.

 

11.         Questions.
 If you have questions regarding these or any other terms and conditions applicable to
your Option, including a summary of the applicable federal income tax consequences please see the Prospectus.

 

*
* * *

 

    4.

     

    
 

Immunome, Inc.

RSU Award Grant Notice

(2020 Equity Incentive Plan)

 

Immunome, Inc. (the “Company”)
has awarded to you (the “Participant”) the number of restricted stock units specified and on the terms
set forth below in consideration of your services (the “RSU Award”). Your RSU Award is subject to all
of the terms and conditions as set forth herein and in the Company’s 2020 Equity Incentive Plan (the “Plan”)
and the Award Agreement (the “Agreement”), which are attached hereto and incorporated herein in their
entirety. Capitalized terms not explicitly defined herein but defined in the Plan or the Agreement shall have the meanings set
forth in the Plan or the Agreement.

 

	Participant:	 
	Date of Grant:	 
	Vesting Commencement Date:	 
	Number of Restricted Stock
    Units:	 

 

	Vesting Schedule:	[__________________________________________________________________].
[The RSU Award shall vest in full upon a Change in Control that occurs during your Continuous Service.] Notwithstanding the foregoing,
vesting shall terminate upon the Participant’s termination of Continuous Service.
	 	 
	Issuance
Schedule:	One
share of Common Stock will be issued for each restricted stock unit which vests at the time set forth in Section 5 of the
Agreement.

 

Participant Acknowledgements: By
your signature below or by electronic acceptance or authentication in a form authorized by the Company, you understand and agree
that:

 

		·	The RSU Award is governed by this RSU Award Grant Notice (the “Grant Notice”),
and the provisions of the Plan and the Agreement, all of which are made a part of this document. Unless otherwise provided in the
Plan, this Grant Notice and the Agreement (together, the “RSU Award Agreement”) may not be modified,
amended or revised except in a writing signed by you and a duly authorized officer of the Company.

 

		·	You have read and are familiar with the provisions of the Plan, the RSU Award Agreement and the
Prospectus. In the event of any conflict between the provisions in the RSU Award Agreement, or the Prospectus and the terms of
the Plan, the terms of the Plan shall control.

 

		·	The RSU Award Agreement sets forth the entire understanding between you and the Company regarding
the acquisition of Common Stock and supersedes all prior oral and written agreements, promises and/or representations on that subject
with the exception of: (i) other equity awards previously granted to you, and (ii) any written employment agreement,
offer letter, severance agreement, written severance plan or policy, or other written agreement between the Company and you in
each case that specifies the terms that should govern this RSU Award.

 

	Immunome, Inc.	 	Participant:
	 	 	 	 
	By:	 	 	 
	 	Signature	 	Signature
	Title:	 	 	Date:	                 
	 	 	 	 	 
	Date:	 	 	 

 

		Attachments:	RSU Award Agreement, 2020 Equity Incentive Plan

 

    

     

    

 

Immunome, Inc.

2020
Equity Incentive Plan

 

Award
Agreement (RSU Award)

 

As reflected by your
Restricted Stock Unit Grant Notice (“Grant Notice”), Immunome, Inc. (the “Company”)
has granted you a RSU Award under its 2020 Equity Incentive Plan (the “Plan”) for the number of restricted
stock units as indicated in your Grant Notice (the “RSU Award”). The terms of your RSU Award as specified
in this Award Agreement for your RSU Award (the “Agreement”) and the Grant Notice constitute your “RSU
Award Agreement”. Defined terms not explicitly defined in this Agreement but defined in the Grant Notice or the Plan
shall have the same definitions as in the Grant Notice or Plan, as applicable.

 

The general terms applicable
to your RSU Award are as follows:

 

1.            Governing
Plan Document. Your RSU Award is subject to all the provisions of the Plan, including
but not limited to the provisions in:

 

(a)          Section 6
of the Plan regarding the impact of a Capitalization Adjustment, dissolution, liquidation, or Corporate Transaction on your RSU
Award;

 

(b)          Section 9(e) of
the Plan regarding the Company’s retained rights to terminate your Continuous Service notwithstanding the grant of the RSU
Award; and

 

(c)          Section 8(c) of
the Plan regarding the tax consequences of your RSU Award.

 

Your RSU Award is further subject to all
interpretations, amendments, rules and regulations, which may from time to time be promulgated and adopted pursuant to the
Plan. In the event of any conflict between the RSU Award Agreement and the provisions of the Plan, the provisions of the Plan shall
control.

 

2.            Grant
of the RSU Award. This RSU Award represents your right to be issued on a future date the
number of shares of the Company’s Common Stock that is equal to the number of restricted stock units indicated in the Grant
Notice as modified to reflect any Capitalization Adjustment and subject to your satisfaction of the vesting conditions set forth
therein (the “Restricted Stock Units”). Any additional Restricted Stock Units that become subject to
the RSU Award pursuant to Capitalization Adjustments as set forth in the Plan and the provisions of Section 3 below, if any,
shall be subject, in a manner determined by the Board, to the same forfeiture restrictions, restrictions on transferability, and
time and manner of delivery as applicable to the other Restricted Stock Units covered by your RSU Award.

 

    

     

    

 

3.            Dividends.
You may become entitled to receive payments equal to any cash dividends and other distributions paid
with respect to a corresponding number of shares of Common Stock to be issued in respect of the Restricted Stock Units covered
by your RSU Award. Any such dividends or distributions shall be subject to the same forfeiture restrictions as apply to the Restricted
Stock Units and shall be paid at the same time that the corresponding shares are issued in respect of your vested Restricted Stock
Units, provided, however that to the extent any such dividends or distributions are paid in shares of Common Stock, then you will
automatically be granted a corresponding number of additional Restricted Stock Units subject to the RSU Award (the “Dividend
Units”), and further provided that such Dividend Units shall be subject to the same forfeiture restrictions and restrictions
on transferability, and same timing requirements for issuance of shares, as apply to the Restricted Stock Units subject to the
RSU Award with respect to which the Dividend Units relate.

 

4.            Withholding
Obligations. As further provided in Section 8 of the Plan, you hereby authorize withholding
from payroll and any other amounts payable to you, and otherwise agree to make adequate provision for, any sums required to satisfy
the federal, state, local and foreign tax withholding obligations, if any, which arise in connection with your RSU Award (the “Withholding
Obligation”) in accordance with the withholding procedures established by the Company. Unless the Withholding Obligation
is satisfied, the Company shall have no obligation to deliver to you any Common Stock in respect of the RSU Award. In the event
the Withholding Obligation of the Company arises prior to the delivery to you of Common Stock or it is determined after the delivery
of Common Stock to you that the amount of the Withholding Obligation was greater than the amount withheld by the Company, you agree
to indemnify and hold the Company harmless from any failure by the Company to withhold the proper amount.

 

5.            Date
of Issuance.

 

(a)          The
issuance of shares in respect of the Restricted Stock Units is intended to comply with Treasury Regulations Section 1.409A-1(b)(4) and
will be construed and administered in such a manner. Subject to the satisfaction of the Withholding Obligation, if any, in the
event one or more Restricted Stock Units vests, the Company shall issue to you one (1) share of Common Stock for each Restricted
Stock Unit that vests on the applicable vesting date(s) (subject to any adjustment under Section 3 above, and subject
to any different provisions in the Grant Notice). Each issuance date determined by this paragraph is referred to as an “Original
Issuance Date.”

 

(b)          If
the Original Issuance Date falls on a date that is not a business day, delivery shall instead occur on the next following business
day. In addition, if:

 

(i)           the
Original Issuance Date does not occur (1) during an “open window period” applicable to you, as determined by the
Company in accordance with the Company’s then-effective policy on trading in Company securities, or (2) on a date when
you are otherwise permitted to sell shares of Common Stock on an established stock exchange or stock market (including but not
limited to under a previously established written trading plan that meets the requirements of Rule 10b5-1 under the Exchange
Act and was entered into in compliance with the Company’s policies (a “10b5-1 Arrangement)), and

 

(ii)          either
(1) a Withholding Obligation does not apply, or (2) the Company decides, prior to the Original Issuance Date, (A) not
to satisfy the Withholding Obligation by withholding shares of Common Stock from the shares otherwise due, on the Original Issuance
Date, to you under this Award, and (B) not to permit you to enter into a “same day sale” commitment with a broker-dealer
(including but not limited to a commitment under a 10b5-1 Arrangement) and (C) not to permit you to pay your Withholding Obligation
in cash,

 

    

     

    

 

(iii)         then
the shares that would otherwise be issued to you on the Original Issuance Date will not be delivered on such Original Issuance
Date and will instead be delivered on the first business day when you are not prohibited from selling shares of the Company’s
Common Stock in the open public market, but in no event later than December 31 of the calendar year in which the Original
Issuance Date occurs (that is, the last day of your taxable year in which the Original Issuance Date occurs), or, if and only
if permitted in a manner that complies with Treasury Regulations Section 1.409A-1(b)(4), no later than the date that is
the 15th day of the third calendar month of the applicable year following the year in which the shares of Common Stock under this
Award are no longer subject to a “substantial risk of forfeiture” within the meaning of Treasury Regulations Section 1.409A-1(d).

 

(c)          To
the extent the RSU Award is a Non-Exempt RSU Award, the provisions of Section 11 of the Plan shall apply.

 

6.            Transferability.
Except as otherwise provided in the Plan, your RSU Award is not transferable, except by will or by
the applicable laws of descent and distribution

 

7.            Corporate
Transaction. Your RSU Award is subject to the terms of any agreement governing a Corporate
Transaction involving the Company, including, without limitation, a provision for the appointment of a stockholder representative
that is authorized to act on your behalf with respect to any escrow, indemnities and any contingent consideration.

 

8.            No
Liability for Taxes. As a condition to accepting the RSU Award, you hereby (a) agree
to not make any claim against the Company, or any of its Officers, Directors, Employees or Affiliates related to tax liabilities
arising from the RSU Award or other Company compensation and (b) acknowledge that you were advised to consult with your own
personal tax, financial and other legal advisors regarding the tax consequences of the RSU Award and have either done so or knowingly
and voluntarily declined to do so.

 

9.            Severability.
If any part of this Agreement or the Plan is declared by any court or governmental authority to be unlawful or invalid, such unlawfulness
or invalidity will not invalidate any portion of this Agreement or the Plan not declared to be unlawful or invalid.  Any
Section of this Agreement (or part of such a Section) so declared to be unlawful or invalid will, if possible, be construed
in a manner which will give effect to the terms of such Section or part of a Section to the fullest extent possible while
remaining lawful and valid.

 

10.          Other
Documents.  You hereby acknowledge receipt of or the right to receive a document
providing the information required by Rule 428(b)(1) promulgated under the Securities Act, which includes the Prospectus.  In
addition, you acknowledge receipt of the Company’s Trading Policy.

 

11.          Questions.
 If you have questions regarding these or any other terms and conditions applicable to
your RSU Award, including a summary of the applicable federal income tax consequences please see the Prospectus.

 

    

     

    
 

Immunome, Inc.

 

(2020
Equity Incentive Plan)

 

NOTICE OF EXERCISE

 

Immunome, Inc.

665
Stockton Drive, Suite 300

	Exton, PA 19341	 	Date of Exercise:
    _______________

 

This constitutes notice
to Immunome, Inc. (the “Company”) that I elect
to purchase the below number of shares of Common Stock of the Company (the “Shares”) by exercising
my Option for the price set forth below. Capitalized terms not explicitly defined in this Notice of Exercise but defined in the
Grant Notice, Option Agreement or 2020 Equity Incentive Plan (the “Plan”)
shall have the meanings set forth in the Grant Notice, Option Agreement or Plan, as applicable. Use of certain payment methods
is subject to Company and/or Committee consent and certain additional requirements set forth in the Option Agreement and the Plan.

 

	Type of option (check one):	 	Incentive   ̈	 	Nonstatutory   ̈
	 	 	 	 	 
	Date of Grant:	 	_______________	 	 
	 	 	 	 	 
	Number of Shares as to which Option is exercised:	 	_______________	 	 
	 	 	 	 	 
	Certificates to be issued in name of:	 	_______________	 	 
	 	 	 	 	 
	Total exercise price:	 	$______________	 	 
	 	 	 	 	 
	Cash, check, bank draft or money order delivered herewith:	 	$______________	 	 
	 	 	 	 	 
	Value of ________ Shares delivered herewith:	 	$______________	 	 
	 	 	 	 	 
	Regulation T Program (cashless exercise)	 	$_____________	 	 
	 	 	 	 	 
	Value of _______ Shares pursuant to net exercise:	 	$_____________	 	 

 

    1.

     

    

 

By this exercise, I
agree (i) to provide such additional documents as you may require pursuant to the terms of the Plan, (ii) to satisfy
the tax withholding obligations, if any, relating to the exercise of this Option as set forth in the Option Agreement, and (iii) if
this exercise relates to an incentive stock option, to notify you in writing within 15 days after the date of any disposition of
any of the Shares issued upon exercise of this Option that occurs within two years after the Date of Grant or within one year after
such Shares are issued upon exercise of this Option.

 

I further agree that,
if required by the Company (or a representative of the underwriters) in connection with the first underwritten registration of
the offering of any securities of the Company under the Securities Act, I will not sell, dispose of, transfer, make any short
sale of, grant any option for the purchase of, or enter into any hedging or similar transaction with the same economic effect as
a sale with respect to any shares of Common Stock or other securities of the Company for a period of one hundred eighty (180) days
following the effective date of a registration statement of the Company filed under the Securities Act (or such longer period as
the underwriters or the Company shall request to facilitate compliance with FINRA Rule 2241 or any successor or similar rule or
regulation) (the “Lock-Up Period”). I further agree to execute and deliver such other agreements as may
be reasonably requested by the Company or the underwriters that are consistent with the foregoing or that are necessary to give
further effect thereto. In order to enforce the foregoing covenant, the Company may impose stop-transfer instructions with respect
to securities subject to the foregoing restrictions until the end of such period.

 

 

	 	Very truly yours,
	 	 
	 	 
	 	 

 

    2.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00314-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00314-of-00352.parquet"}]]